Wright State University

CORE Scholar
Browse all Theses and Dissertations

Theses and Dissertations

2013

Elucidating a Role of Btf and TRAP150 in pre-mRNA Processing
and Cell Cycle Progression
Sapna N. Varia
Wright State University

Follow this and additional works at: https://corescholar.libraries.wright.edu/etd_all
Part of the Biomedical Engineering and Bioengineering Commons

Repository Citation
Varia, Sapna N., "Elucidating a Role of Btf and TRAP150 in pre-mRNA Processing and Cell Cycle
Progression" (2013). Browse all Theses and Dissertations. 1135.
https://corescholar.libraries.wright.edu/etd_all/1135

This Dissertation is brought to you for free and open access by the Theses and Dissertations at CORE Scholar. It
has been accepted for inclusion in Browse all Theses and Dissertations by an authorized administrator of CORE
Scholar. For more information, please contact library-corescholar@wright.edu.

	
  
	
  

Elucidating a Role of Btf and TRAP150 in pre-mRNA
Processing and Cell Cycle Progression

A dissertation submitted in partial fulfillment of the
requirements for the degree of
Doctor of Philosophy

By
SAPNA VARIA
M.S., Gujarat University, India, 2002.

_____________________
2013
Wright State University
	
  
	
  
	
  
	
  
i	
  	
  
	
  

	
  
	
  

WRIGHT STATE UNIVERSITY
SCHOOL OF GRADUATE STUDIES
May 24th, 2013.
I HEREBY RECOMMEND THAT THE DISSERTATION PREPARED
UNDER MY SUPERVISION BY SAPNA VARIA ENTITLED Elucidating a Role of Btf and TRAP150 in
pre-mRNA Processing and Cell Cycle Progression BE ACCEPTED IN PARTIALFULFILLMENT OF
THE REQUIREMENTS FOR THE DEGREE OF Doctor of Philosophy.

__________________________
Paula Bubulya, Ph.D.
Dissertation Director
__________________________
Gerald Alter, Ph.D.
Director, Biomedical Sciences,
Ph.D. Program

__________________________
R. William Ayres, Ph.D.
Interim Dean, Graduate School
Committee on Final Examination
____________________
Paula Bubulya, Ph.D.
____________________
Mark Mamrack, Ph.D.
____________________
Gerald Alter, Ph.D.
____________________
David Cool, Ph.D.
____________________
Scott Baird, PhD.

ii	
  	
  
	
  

	
  
	
  

ABSTRACT
SapnaVaria, PhD Biomedical Sciences, Biological Sciences Department,
Wright State University, Dayton, Ohio, 2013. Elucidating a Role of Btf
and TRAP150 in pre-mRNA Processing and Cell Cycle Progression.

Transcription of protein-coding genes is coordinated with pre-mRNA processing
as well as mRNP assembly and nuclear export in mammalian cells. In this dissertation, I
examined the functions of two homologous non-classical serine-arginine-rich (SR)
proteins, Btf (BCLAF1) and TRAP150 in these steps of gene regulation. Since Btf and
TRAP150 share 39% sequence identity and 66% sequence similarity, I also examined
whether Btf and TRAP150 have overlapping or distinct functions in pre-mRNA
processing. Using two different reporter loci, I showed in-situ recruitment of Btf and
TRAP150 at reporter transcription sites, and I identified both Btf and TRAP150 being
associated with a core EJC component Magoh. However, my data indicate that these
proteins have different roles in maintaining the cellular mRNA distribution in HeLa cells.
My data demonstrate that Btf depletion, but not compensatory TRAP150 up-regulation,
leads to a global change in cellular distribution of mRNA. Thus, my data reveal that
modulating the expression of a single protein, Btf, has global impact upon the
nuclear/cytoplasmic distribution of mRNAs. In addition, HeLa cells depleted of Btf and
TRAP150 showed chromosomal misalignment at metaphase. This suggests that both
proteins regulate the mitotic progression of HeLa cells. My exon microarray data show
cell cycle and mitosis as the major processes being affected in Btf or TRAP150
depleted HeLa cells. In all, my results suggest that both Btf and TRAP150 have distinct
but important roles in maintaining mRNA distribution in cells, but they are both important
for mitotic progression. Future studies will determine if absence of Btf or TRAP150
leads to altered processing of endogenous transcripts encoding cell cycle regulator
proteins, thereby affecting the cellular distribution of these mRNAs and providing a
mechanism for mitotic regulation by Btf and TRAP150.

iii	
  
	
  
	
  

	
  
	
  

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION ........................................................................................ 1
mRNA export and Exon Junction Complex proteins .................................................... 5
Nuclear Domains ......................................................................................................... 10
Nuclear Speckles ........................................................................................................ 11
Components of Nuclear Speckles ............................................................................... 14
SR Proteins ................................................................................................................. 17
BCLAF1/ Btf and TRAP150/THRAP3 ......................................................................... 20
Domain structure and subcellular localization of Btf and TRAP150 ........................ 21
Association of Btf and TRAP150 with Ribonucleoprotein complexes (RNP) .......... 27
Mitosis ........................................................................................................................ 28
Spindle Assembly Checkpoint (SAC) ..................................................................... 28
Role of SR proteins in cell cycle regulation ............................................................. 32
Rationale and Hypothesis .......................................................................................... 34
CHAPTER 2: MATERIALS AND METHODS ................................................................. 36
CHAPTER 3: RESULTS FOR AIM1
To examine the role of Btf and/or TRAP150 in pre-mRNA processing .......................... 48
CHAPTER 4: RESULTS FOR AIM2
Btf and TRAP150 are important for proper mitotic progression ................................... 128
CHAPTER 5: DISCUSSION ........................................................................................ 180
CHAPTER 6: CONCLUSION ...................................................................................... 191
APPENDIX .................................................................................................................. 195
REFERENCES ............................................................................................................. 205
iv	
  
	
  
	
  

	
  
	
  

LIST OF FIGURES

Figure i. A Contemporary theory of gene expression ...................................................... 2
Figure ii. Schematic representation of spliceosomal assembly and disassembly
cycle ................................................................................................................................. 6
Figure iii. EJC complex loading on pre-mRNA ................................................................ 8
Figure iv. A schematic diagram of various nuclear domains in mammalian cell nucleus
........................................................................................................................................ 12
Figure v. A piechart representing the proteomic analysis of nuclear speckle components
........................................................................................................................................ 15
Figure vi. Schematic diagram of various domains of Btf and TRAP150 ......................... 23
Figure vii. A graphical representation of the alignment of Btf and TRAP150 ................. 25
Figure viii. The spindle checkpoint proteins ................................................................... 30
Figure 1. WU10 Antibody Preparation and its Specificity ............................................... 50
Figure 2. Endogenous and Exogenous Btf and TRAP150 localize to nucleoplasmic foci
with some overlay with nuclear speckles in U2OS cells ................................................. 53
Figure 3. Localization of TRAP150 and Btf is dependent on RNA Polymerase II
activity............................................................................................................................. 55
Figure 4. Btf and TRAP150 localize at BTM transcription sitesin situ ............................ 58
Figure 5. Fibrillarin or PML body is not present at the BTM locus ................................. 60
Figure 6. Schematic representation of the YFP-Btf deletion mutants ............................ 62
Figure 7. The region 540-640 in full-length YFP-Btf regulates the immunolocalization of
YFP-Btf in nucleoplasmic foci in HeLa cells ................................................................... 65
Figure 8. RS domain of YFP-Btf is sufficient to localize to BTM reporter RNA .............. 67
Figure 9. U2OS 2-6-3 cells allow visualization of gene expression in living cells .......... 71
Figure 10. Btf and TRAP150 localize at U2OS 2-6-3 reporter locus transcription sitesin
situ .................................................................................................................................. 73
Figure 11. Localization of Btf and TRAP150 at a transcription site is dependent on RNA
Polymerase II activity ..................................................................................................... 75

v	
  	
  
	
  

	
  
	
  

Figure 12. Btf and TRAP150 do not colocalize with transcriptional activator at the U2OS
2-6-3 reporter locus ........................................................................................................ 78
Figure 13. SRSF1 localization on the transcriptionally active U2OS 2-6-3 array ........... 81
Figure 14. Btf and TRAP150 colocalize with each other extensively at transcription sites
in-situ .............................................................................................................................. 83
Figure 15. Immunolocalization of YFP-Btf deletion mutants is similar in U2OS cells to
HeLa cells ....................................................................................................................... 85
Figure 16. YFP-Btf deletion mutants co-localize with TRAP150 at active U2OS 2-6-3
transcription sites ........................................................................................................... 87
Figure 17. Btf co-localize with SRSF1 at active transcription sitesin-situ ....................... 90
Figure 18. TRAP150 co-localize with SRSF1 at active transcription sitesin-situ ............ 92
Figure 19. Btf and TRAP150 co-localize with the splicing factor SRSF1 at the active
U2OS 2-6-3 reporter locus ............................................................................................. 94
Figure 20. Btf and TRAP150 colocalize extensively with the exon junction complex
component Magoh .......................................................................................................... 96
Figure 21. Btf and TRAP150 colocalize with the splicing factor SRSF1 and exon junction
complex component Magoh at a constitutively active Rat Beta-tropomyosin minigene
locus ............................................................................................................................... 98
Figure 22. TRAP150 and Magoh co-immunoprecipitate with Btf ................................. 100
Figure 23. Immunoprecipitation of Btf to identify endogenous interacting partners ..... 102
Figure 24. Depletion of Btf or TRAP150 does not alter splicing on BTM transcripts but
increases abundance of total BTM transcripts in the cell. ........................................... 105
Figure 25. Depletion of Btf and not TRAP150 increases levels of BTM transcripts in the
cytoplasm ..................................................................................................................... 108
Figure 26. Depletion of Btf does not prevent recruitment of SF2/ASF to the BTM
transcription sites ......................................................................................................... 111
Figure 27. Depletion of Btf does not prevent recruitment of TRAP150 to the BTM
transcription sites ......................................................................................................... 113
Figure 28.Depletion of Btf does not prevent recruitment of Magoh to the BTM
transcription sites ......................................................................................................... 115

vi	
  
	
  
	
  

	
  
	
  

Figure 29. Cytoplasmic polyadenylated RNA increases following depletion of Btf but not
TRAP150 ...................................................................................................................... 119
Figure 30. Upregulation of TRAP150 following Btf depletion can be prevented by adding
limiting amounts of TRAP150siRNAoligos ................................................................... 122
Figure 31. Cytoplasmic polyadenylated RNA increases in Btf-depleted cells when
compensatory upregulation of TRAP150 is blocked .................................................... 124
Figure 32. Depletion of Btf or TRAP150 does not cause any change in the distribution of
Malat1 or U2snRNA ..................................................................................................... 126
Figure 33. Depletionof Btf causes misalignment of chromosomes at metaphase ........ 129
Figure 34. Depletion of TRAP150 causes chromosomal defects at telophase ............ 131
Figure 35. Depletion of Btf causes an increase in mitotic index ................................... 133
Figure 36. Depletion of Btf and TRAP150 in HeLa cells shows an increase in G2/M
phase cells ................................................................................................................... 136
Figure 37. Localization of CENP-E to misaligned chromosomes at metaphase in Btfdepleted cells ............................................................................................................... 139
Figure 38. CENP-F localizes to misaligned chromosomes at metaphase in Btf-depleted
cells .............................................................................................................................. 141
Figure 39. Aurora B localizes to misaligned chromosomes at metaphase in Btf-depleted
cells .............................................................................................................................. 143
Figure 40. Upregulation of Aurora B protein expression in Btf-depleted cells .............. 145
Figure 41. Cell cycle progression in HeLa cells stably expressing H2B-YFP .............. 149
Figure 42. Mitosis does not progress past metaphase after Btf depletion in HeLa cells
stably expressing H2B-YFP ......................................................................................... 151
Figure 43. Time-lapse imaging of chromosome misalignment at metaphase after Btf
depletion in HeLa cells stably expressing H2B-YFP .................................................... 153
Figure 44. Double depletion of Btf and TRAP150 in HeLa cells causes mitotic arrest . 160
Figure 45. Btf and TRAP150 affects cell viabiity and growth in HeLa cells .................. 157
Figure 46. Depletion of Btf and TRAP150 causes mitotic arrest .................................. 159
Figure 47. Time-lapse imaging showing chromosomal segregation defects in cells
depleted of Btf and TRAP150 ....................................................................................... 161

vii	
  
	
  
	
  

	
  
	
  

Figure 48. Time-lapse imaging showing mitotic defects in cells depleted of Btf and
TRAP150 ...................................................................................................................... 165
Figure 49. Time-lapse imaging showing missegregation defects in cells depleted of Btf
and TRAP150 ............................................................................................................... 167
Figure 50. Immunoblot analysis showing depletion of Btf or TRAP150 in samples used
for Exon array ............................................................................................................... 172
Figure 51. Graphical representation of the most significant GoProcess groups affected
by Btf depletion in Exon array by Altanalyze program .................................................. 174
Figure 52. Graphical representation of the differential gene expression for the most
significantly affected pathway groups in Btf depleted cells .......................................... 176
Figure 53. Validation of upregulation for major checkpoint protein transcripts upon Btf or
TRAP150 depletion ...................................................................................................... 178
Figure 54. A model proposing that Btf or TRAP150 behave as adaptor proteins, thereby
regulating the cellular distribution of mRNA ................................................................. 192

	
  

viii	
  
	
  
	
  

	
  
	
  

LIST OF TABLES

Table 1. Top 20 most significant gene transcripts Up-regulated upon Btf depletion in
Exon Array .................................................................................................................... 197
Table 2. Top 20 most significant gene transcripts Down-regulated upon Btf depletion in
Exon Array .................................................................................................................... 198
Table 3. Top 20 most significant genes Up-regulated upon TRAP150 depletion in Exon
Array ............................................................................................................................. 199
Table 4. Top 25 most significant genes Down-regulated upon TRAP150 depletion in
Exon Array .................................................................................................................... 200
Table 5. List of genes showing Down-regulation of Exon inclusion (Exon skipping) upon
Btf depletion (BtfSi1) in Exon Array .............................................................................. 201
Table 6.List of genes showing Up-regulation of Exon inclusion upon Btf depletion in
Exon Array .................................................................................................................... 202
Table 7. List of genes showing Down-regulation of Exon-inclusion (Exon skipping) upon
TRAP150 (TRAPSi4) depletion in Exon Array ............................................................. 203
Table 8.List of genes showing Up-regulation of Exon inclusion upon TRAP150 depletion
(TRAPSi4) in Exon Array .............................................................................................. 204
Table 9. Primer sequences for mitotic gene targets ..................................................... 205
Table 10. Differentially expressed major chromosomal passenger genes after Btf and
TRAP150 depletion in Affymetrix HumanExon10ST Array .......................................... 206
	
  

ix	
  
	
  
	
  

	
  
	
  

AKNOWLEDGEMENTS

I would like to express my deeply felt thanks to my thesis advisor Dr. Paula Bubulya for
all her support and guidance. I have been able to become a true scientist truly because
of her constant encouragement and guidance. I would also like to thank Dr. Athanasios
Bubulya, who has always guided me to the right direction in science. Thoughtful
conversations with him have always geared my thoughts and forced me to think from all
the perspective in an experiment.
I am grateful to my committee members Dr. Mark Mamrack, Dr. David Cool, Dr. Gerald
Alter, Dr. Scott Baird for all their valuable suggestions and ideas for my thesis.
I would also like to thank past and present members of Bubulya lab. I truly appreciate
the help received from Tripathi Vidisha, Prasanth K.V., (Univ. of Illinois, UrbanaChampaign, IL), Dr. Sulentic and Dr, Gomez-Cambronero (Wright State University).
I would also like to thank my friends Priyanka Sharma and Monita Sharma for their help,
support and encouragement.
Most importantly, my sincere thanks to my husband Niraj Varia. My PhD thesis is the
result of his support, encouragement, help and love. He has made me feel special even
when times were tough for me. He has been my pillar of strength through all ups and
downs. I am blessed to have a life partner like him.
Finally, I would like to dedicate my thesis to my beloved Father. He was my inspiration
and strength and my mom who has given me the true values of life and always inspired
me to work hard in order to achieve success. I would also like to thank my sister Jigna
Nyaya and brother Samir Shah for all their support and encouragement.

x	
  	
  
	
  

	
  
	
  

xi	
  
	
  
	
  

	
  
	
  

CHAPTER 1
Introduction
Expression or eukaryotic protein-coding genesrequires a series of sequential
events, starting with transcription of the gene into pre-mRNA, and followed bypre-mRNA
processing, mRNA nuclear export and translation of mature mRNAs. Each of these
processes occurs with the help of large macromolecular complexes such as RNAprotein (RNP) complexes. Multicellular organisms control cell differentation through
precise spatio-temporal localization of these complexes in cells and thereby regulate
gene expression. In order to fully understand the various steps in gene expression, it is
crucial to understand specific functions for the various factors involved in these
processes. In this thesis, an effort has been made to understand the functions of the
nuclear speckle proteins Btf and TRAP150 in controlling gene expression and cell
growth in human cells.
Efficient gene expression requires transcription of genes by RNA polymerase II,
pre-mRNA splicing and 3' end processing. Transcripts from protein-coding genes are
produced by RNA polymerase II and are called pre-messenger RNAs (pre-mRNAs). A
series of co-transcriptional pre-mRNA processing steps, including 5' capping, splicing,
and 3’ cleavage/polyadenylation, occur prior to nuclear export and translation of mature
mRNAs into protein (Figure i)(Reinberg, 2002; Rodríguez-Navarro S, 2011). Gene
expression is highly regulated and controlled at two different levels. First, transcription is
controlled to limit the amount of mRNA being produced from a particular gene. Second
level of control is through post-transcriptional events that regulate the expression of
protein from mRNA. The post-transcriptional events include 5' capping, pre-mRNA
splicing, 3' end polyadenylation. These processes occur co-transcriptionally and are
highly dynamic and interdependent. 5’ end processing of the nascent RNA produced
(pre-mRNA) occurs co-transcriptionally by addition of a cap that consists of a modified
guanine nucleotide. This capping process occurs in three steps (Hocine S, 2010; Soller,
2006). A N7-methyl GMP as the 5’ end of the nascent transcript is capped by addition of
a guanylyl residue. A phosphatase enzyme removes the phosphate group at the 5’ end
and another enzyme called guanylyltransferase adds a 7-methylguanosine (m7G) using
1	
  	
  
	
  

	
  
	
  

Figure i. A contemporary theory of gene expression (Reinberg, 2002).
Gene expression events are coupled to ensure that no step of gene expression is
omitted. This organization of events introduces a series of quality control mechanisms.
The various steps of co-transcriptional processes include 5’ capping, splicing, cleavage
and polyadenylation. Mature mRNA is then exported to the cytoplasm through nuclear
pores via exon junction complex proteins (in green circles). The process of translation
and protein folding then occurs in the cytoplasm.
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(Reinberg, 2002)
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GTP as a substrate. The cap-binding complex (CBC) regulates nuclear export of RNA
byrecognizing and binding to the capped RNA. The CBC is then recognized by the
nuclear pore complex and exported to the cytoplasm. In the cytoplasm, after the first
round of translation, the CBC is replaced with eIF-4E and eIF-4G. The translation
machinery then recognizes this complex.
The process of removal of introns or intergenic sequences (non-coding) from premRNA and ligation of the exons or coding sequences is called splicing. Pre-mRNA
splicing is catalyzed by a two-step mechanism. In the first step of splicing, the 2’ OH
group of the branchpoint adenosine attacks the phosphate at the 5’ splice site, resulting
in and exon with 3’ OH group. In the second step this 3’ OH of the 5’ exon group attacks
the 3’ phosphate at the splice site and thus releases the intron in lariat form. Splicing is
carried out by large molecular complexes called small ribonucleoproteins (snRNP) U1,
U2, U4/U6 and U5. Nuclear hnRNAs associate with different proteins called small
nuclear ribonucleoprotein particles (snRNPs) to form RNA-protein complexes. The
spliceosome assembly is an ordered process with several intermediates including
complex E, A, B* and C as shown in Figure ii (Will and Lu¨hrmann, 2006; Will and
Luhrmann, 2011; Will and Lührmann, 2011a). The C-terminal domain (CTD) of the large
subunit of RNA polymerase II serves as a platform for co-transcriptional coordination of
RNA processing events and assembly of these complexes (Bentley, 2005; Maniatis and
Reed, 2002; Neugebauer, 2002). Spliceosome assembly is initiated by binding of U1
snRNP to the 5' splice site, with simultaneous binding of U2 snRNP to the 3' splice site
and U2 auxilliary factor (U2AF) to the polypyrimidine tract. Alternative splicing is
responsible for the generation of different mRNA isoforms that may differ in their open
reading frames or stability by either inclusion or exclusion of exons in the protein coding
regions of the pre-mRNA. All pre-mRNA processing events are carried out in
conjunction with one another by large spliceosomal complexes. Alternative splicing is an
important mechanism to increase functional diversity of the proteome in higher
eukaryotes. A variety of factors influence alternative splicing events including differential
regulation of various splicing regulatory proteins. The regulation of splicing is
complicated and currently an area of major scientific research. Cis-acting regulatory
4	
  	
  
	
  

	
  
	
  

sequences embedded within exons and introns promote either enhancement or
repression of splicing (Black, 2003). There are four categories of alternative splicing
regulatory sequences: exon splicing enhancers (ESEs), exon splicing silencers (ESSs),
intron splicing enhancers (ISE) and intron splicing silencers (ISSs) (Black, 2003). The
ESE regions are generally targeted by serine-arginine (SR) family of proteins that
regulate alternative splicing of nearby exons(Black, 2003; Tacke and Manley, 1999), but
also impact mRNA export (Huang et al., 2003), nonsense-mediated mRNA decay
(Zhang and Krainer, 2004) and mRNA translation (Sanford et al., 2004).
After pre-mRNA splicing the mature transcript undergoes 3' end processing or
polyadenylation. Transcription of pre-mRNAs by RNA polymerase II continues beyond
what will become the 3’ end of the mature RNA. The termination reaction occurs after
the RNA polymerase encounters a consensus AAUAAA sequence known as a
polyadenylation signal. This is followed by a GU-rich sequence that is the site of
cleavage. Two multisubunit protein complexes called cleavage and polyadenylation
specific factor (CPSF) and cleavage stimulation factor (CstF) are recruited from the Cterminal domain (CTD) of RNA polymerase II to the nascent pre-mRNA molecule; they
cleave the RNA between the polyadenylation signal sequence and the GU-rich
sequence. Another protein complex including polyadenylate polymerase (PAP) is also
transferred to the pre-mRNA and adds~200 adenine residues using ATP as a substrate.
Subsequent maturation steps further packagethe mRNA into mRNP prior to mRNP
export to the cytoplasm.
mRNA Export and Exon Junction Complex Proteins
Nuclear export of mRNA occurs through the nuclear pore complexes (NPCs).
Mature mRNA is exported to the cytoplasm for translation into protein. The mRNA to be
exported is not just naked RNA but a complex of protein and RNA, hence called
ribonucleoprotein particle or mRNP. During the second step of splicing, the exon-exon
junction complex proteins are loaded onto the mRNA in a sequence-independent
manner, approximately 20-25 nucleotides upstream of an exon junction. This complex
marks the mRNA for export. It is comprised of core components including Magoh,
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Figure ii. Schematic representation of spliceosomal assembly and disassembly
cycle (Will and Lu¨hrmann, 2006).
Spliceosomal assembly is initiated by U1 and U2 snRNPs forming complex E. Later, an
ATP catalyzed reaction forms a stable association of U1 and U2 with the pre-mRNA
forming complex A, or the pre-spliceosomal complex. In the next step, the tri-snRNP
associates to form complex B or pre-catalytic complex. This then undergoes major
rearrangements to form the activated spliceosomal complex B*.
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(Will and Lu¨hrmann, 2006; Will and Lührmann, 2011b)
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Figure iii. EJC complex loading on pre-mRNA(Le Hir et al., 2001).
Core proteins in EJC like Y14, Srm160, REF, DEK, RNPS1, Magoh load onto premRNA upstream of exon-exon junction. After splicing TAP/p15 heterodimer along with
Upf3 associates with the EJC proteins and RNA in the nucleus and help in export of the
RNP through nuclear pore. Nucleo-cytoplasmic shuttling proteins like RNPS1, SRm160,
REF dissociate in the cytoplasm while Y14 remains stably attached to the mRNA.
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(Le Hir et al., 2001).
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Aly/REF, RNPS1, Y14, SRm160 and others (Kataoka et al., 2001; Kataoka et al., 2011;
Kataoka and Dreyfuss, 2004; Le Hir et al., 2001; Le Hir et al., 2000). This then recruits
the export factor TAP to the pre-mRNA to promote export through the nuclear pore into
the cytoplasm as shown in Figure iii. SRm160, DEK and RNPS1 are either directly or
indirectly associated with pre-mRNA splicing (Blencowe et al., 1998; Mayeda et al.,
1999; McGarvey et al., 2000). REF and Y14 are RNA binding proteins important for
mRNA export (Rodrigues et al., 2001; Stutz et al., 2000; Zhou et al., 2000)
Nuclear Domains
All these pre-mRNA processing events are highly coordinated and spatially
organized in the mammalian nucleus. In recent years, there has been increased
understanding of the structural organization of the nucleusand how it influences
transcription and pre-mRNA processing. The nucleus is a highly dynamic and
compartmentalized structure of mammalian cells. Nuclear factors having fundamentally
different functions localize indistinct sub-nuclear structures referred to as "nuclear
domains". A number of nuclear domains have been identified such as nuclear speckles,
perichromatin fibrils, Cajal bodies, paraspeckles, promyelocytic leukemia bodies (PML)
and others as shown in Figure iv (Spector, 2001). Splicing factors reside in nuclear
speckles and in Cajal bodies (Gall et al., 1999). Cajal bodies play a role in snRNP
biogenesis or trafficking of snRNPs and snoRNPs. Spliceosomal U1, U2, U4/U6 and U5
snRNPs all localize to these domains. Cleavage and polyadenylation factors are
present in cleavage bodies (Schul et al., 1996). These structures either overlap or are
adjacent to Cajal bodies. The subset of cleavage bodies that do not overlap with Cajal
bodies has newly synthesized RNA. The nucleolus is the site of ribosomal assembly,
rRNA synthesis and processing (Shaw and Jordan, 1995). The perinucleolar
compartment (PNC) and SAM68 nuclear body (Huang, 2000) associate with nucleoli
and play a role in RNA metabolism. PML protein, Sp100, SUMO1, HAUSP and CBP
localize to PML bodies (Maul et al., 2000) and play a role in transcriptional regulation
and are targets for viral infection.
In addition to their diffuse distribution in the nucleoplasm, pre-mRNA splicing
factors also localize in a pattern of 25-50 interchromatin granules as evident by electron
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microscopy. These interchromatin granule clusters are termed "nuclear speckles". It is
postulated that these interchromatin granules represent a variety of RNPs at multiple
stages of biogenesis and/or assembly. My dissertation focuses on characterizing two
homologous nuclear speckle components - Btf and TRAP150, and analyzing their
function in pre-mRNA processing.
Nuclear Speckles
Pre-mRNA splicing factors, including both the small ribonucleoprotein particles
(snRNPs) and non-snRNPs, are found in a discrete localization pattern in the
nucleoplasm in mammalian cells. This localization pattern is sometimes termed “splicing
speckles” or “splicing factor compartments”, but most often is referred to as “nuclear
speckles”. J. Swanson Beck was the first person to introduce the term “speckles” while
immunolabeling rat-liver sections with the antisera of individuals suffering from
autoimmune disorders (Beck, 1961). But earlier, Hewson Swift had identified these
structures by electron microscopic studies (Swift, 1959). Electron microscopic
examination of nuclear speckles revealed small clusters of granules 20-25 nm in
diameter, present in between euchromatic nuclear regions and hence led to the term
“interchromatin granule clusters (IGCs)” (Spector, 2001). Clusters of interchromatin
granules or nuclear speckles are located throughout the nucleoplasm in regions where
there is little or no DNA (Thiry, 1995). Fluorescent microscopy studies have shown that
the majority of active genes are present at the periphery of speckles and are excluded
from the speckles (Dirks et al., 1997; Huang and Spector, 1991). These observations
led to the hypothesis that IGCs are not sites of active transcription but instead they are
proposed to be storage, assembly and/or modification sites for pre-mRNA splicing
factors. All proteins involved in pre-mRNA splicing such assnRNPs, SR proteins, and
other pre-mRNA transcription/processing factors, are enriched in nuclear speckles in
addition to their diffuse distribution throughout the nucleoplasm (Spector et al., 1993).
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Figure iv. A schematic diagram of various nuclear domains in the mammalian cell
nucleus (Spector, 2001).
This is a schematic diagram of a mammalian cell nucleus. Various non-membrane
bound nuclear domains were identified based on their immunolocalization pattern and
function such as PcG body, Cajal body, Gem, PML body, nucleolus, nuclear speckles
and others.
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(Spector, 2001)
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Components of Nuclear Speckles
Fluoroscence microscopy was among the first tools to reveal composition of
nuclear speckles. Nuclear speckle localization of specific factors included components
such as polyadenylated RNA (Carter et al., 1991; Carter et al., 1993; Huang et al.,
1991), splicing factors such as splicing factor 2/alternative splicing factor (SF2/ASF;
SRSF1) and SC35 (Lamond and Spector, 2003) and small nucler RNAs such as U1,
U2, U4, U5 and U6 that are assembled into snRNPs. Later, proteomic analysis of IGCs
purified from mouse liver nuclei identified more than146 proteins (Mintz et al, 1999;
Saitoh et al., 2004), majority of which are linked to pre-mRNA processing functions such
as capping, splicing and polyadenylation. Proteomic analysis also revealed 33
novelcomponents of nuclear speckles, most of which still remain to be characterized
(Mintz et al, 1999; Saitoh et al., 2004). The majority of identified nuclear speckle
proteins had functions in pre-mRNA processing: (54%) were splicing factors, 20% were
RNA-associated proteins, 4% were cleavage and polyadenylation factors, 3% were
transcription factors and 3% were RNA polymerase II subunits (Figure v). Although
transcription does not take place in nuclear speckles, the higher order assembly or
modification of specific transcription factors could depend ontheir association with
nuclear speckles. Apart from their protein components, nuclear speckles are also
enriched in a subset of RNAs such as poly (A)+ RNA (Carter et al., 1991; Huang et al.,
1994; Visa et al., 1993) and numerous non-coding RNA (ncRNA) (Kapranov et al.,
2002; Matera et al., 2009; Van Bakel et al., 2010). These ncRNAs are classified into
short (18-200nt) and long (200 to ˃100kb) ncRNAs (Prasanth and Spector, 2007).
Thenuclear

retained

non-coding

RNA

MALAT1

(metastasis-associated

lung

adenocarcinoma transcript 1) (Hutchinson et al., 2007; Prasanth and Spector, 2007;
Wilusz et al., 2009) is one such example that regulates alternative splicing by
modulating SF2/ASF phosphorylation, thereby influencing the nuclear distribution and
splicing regulation by SF2/ASF and other SR proteins (Tripathi et al., 2010).
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Figurev. A piechart representing the proteomic analysis of nuclear speckle
components (Saitoh et al., 2004)
Proteomic analysis of nuclear speckles identified splicing factors as major components
along with other factors involved in RNA processing such as mRNA export factors,
transcription factors, cleavage and polyadenylation factors. Those factors designated as
“others” have unknown functions. My thesis focuses on characterizing two
uncharacterized proteins in the “others” category, called Btf and TRAP150.
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SR proteins
SR proteins were first identified as splicing factors in early 1990s. The SR protein
family consists of phylogenetically conserved proteins that contain a characteristic
domain rich in serine and arginine residues, or “RS domain”. SF2/ASF was the first SR
protein to be identified as a splicing factor, as it was able to complement splicing in a
splicing-deficient HeLa S100 cytoplasmic extract (Krainer et al., 1990). Identification of
various other RS domain-containing proteins by monoclonal antibody mAb104 revealed
other SR proteins such as SC35 (spliceosomal complex 35), SRp20, SRp40, SRp50,
SRp75 (Roth et al., 1990; Zahler et al., 1992). These SR proteins were conserved
across vertebrates and invertebrates. Classical SR proteins contain either one or two
modular RNA-recognition motifs (RRMs) at the N-terminus that provides RNA binding
specificityand a COOH-terminal domain rich in serine/argininedipeptides (RS domain)
that provides protein-protein interactions that facilitate the recruitment of splicing factors
and assembly of spliceosomes (Kohtz et al., 1994; Wu and Maniatis, 1993).
Additionally, the RS domain acts as a nuclear localization signal (NLS) affecting the
subcellular localization of SR proteins by interacting with the SR protein nuclear import
factor transportin-SR (Ge and Manley, 1990; Roth et al., 1990).
A genome-wide study identified many different RS domain-containing proteins in
metazoans having roles not only in splicing but other cellular processes such as
chromatin remodeling, transcription and cell cycle progression (Boucher et al., 2001).
These RS domain-containing proteins differed from classical SR proteins in their overall
domain structure and lacked a defined RRM and thus were termed as "SR-like proteins"
(Fu, 1995). In this thesis, two such SR-like proteins, called Btf and TRAP150, have
been studied to elucidate their role in pre-mRNA processing.
Role of SR proteins in splicing, mRNA export and nonsense-mediated mRNA
decay (NMD)
The major function of SR proteins is for splice-site selection during pre-mRNA
splicing. SR proteins interact with exonic splicing enhancers (ESEs) to promote
recognition of the 3’ splice site by U2AF and the 5’ splice site by U1 snRNP. SR
proteins

are

negative

regulators

of
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ribonucleoproteins) bound to exonic splicing silencers (ESSs).Modulation between SR
protein binding to ESEs and hnRNP binding to ESSs controls alternative splicing in
mammals (Fu, 1995; Ibrahim et al., 2005; Manley and Tacke, 1996). SR proteins also
function in post-splicing events such as mRNA export, NMD and translation (Huang and
Steitz, 2005). Most of the SR proteins are exclusively nuclear, but some are
nucleocytoplasmic shuttling SR proteins such as SRSF1 (SF2/ASF), SRp20 and 9G8
(Caceres et al., 1998), that have roles in nucleo-cytoplasmic export of mRNA (Huang et
al., 2003; Huang and Steitz, 2001; Huang et al., 2004). These shuttling SR proteins
provide adaptor functions for mRNA export by recruiting general mRNA export factor
TAP/NXF1 to spliced mRNAs (Huang et al., 2003). SR proteins bind to the same Nterminal domain of NXF1 that associates with the family of REF/Aly adaptor proteins
(Dimaano and Ullman, 2004). The phosphorylated status of the SR proteins is important
for their role in post splicing events. A hypophosphorylated form of the RS domain in SR
proteins was required for their interaction with the nuclear export factor TAP/NXF1 for
mRNA export (Huang et al., 2004; Lai and Tarn, 2004). In the cytoplasm, the
dephosphorylated form of SF2/ASF enhances its binding to mRNA and thus contributes
toits role in translation (Sanford et al., 2005). Also, phosphorylation of serines in the RS
domain of SR proteins releases them from their storage site in nuclear speckles, and
they are recruited to sites of active transcription (Jimenez-Garcia et al., 1993; Lamond
and Spector, 2003; Misteli et al., 1998; Misteli and Spector, 1996; Spector et al., 1993).
The mechanisms that regulate the cycling of factors into and out of the nuclear
speckles, as well as to active transcription sites, is still unknown. Similarly, Btf and
TRAP150 proteins that are discussed in this thesis might be hyperphosphorylated since
they localize to discrete nucleoplasmic foci and are not enriched in nuclear speckles.
Also, they have been demonstrated to be in a complex with various protein complexes
having roles in pre-mRNA processing and the export factorcd TAP/NXF1. Thus, they
might be important in some steps of mRNA metabolism.
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SR proteins and human diseases
Disruption in the functions of SR proteins can lead to various diseases such as
cancer, HIV, SMA (Spinal Muscular Atrophy) and many others. The vast majority of
such diseases result in improper splicing, thereby causing incorrect exon skipping or
exoninclusion in mRNAs. The mis-expression of many SR proteins have been linked to
development of cancer mainly as a result of changes in the pattern of alternative
splicing pattern of target transcripts. The classical SR protein SRSF1 is a
protooncogene that is upregulated in various types of cancer (Karni et al., 2007). HIV-1
generates more than 40 different mRNAs from its single full-length genomic pre-mRNA
by alternative splicing. Various SR proteins have been demonstrated to have a role in
regulating the alternative splicing events affecting the viral transcripts. For instance,
SRp75, SRSF1, SRp40 have been demonstrated to bind to viral ESEs and thus cause
exon inclusion of viral exons(Asang et al., 2008; Exline et al., 2008; Stoltzfus and
Madsen, 2006). Furthermore, HIV infection induces changes in the expression of
splicing factors that regulate alternative viral splicing and viral replication (Dowling et al.,
2008).Loss of a functional SMN1 (survival of motor neuron 1), which is a key
component of snRNP biogenesis, leads to hereditary neurogenerative disease called
spinal muscular atropy (SMA). A single C-T transition in exon 7 of SMN1 paralogue
leads to the production of non-functional protein. This exon-skipping event has been
attributed to either the loss of SRSF1-dependent exonic splicing enhancer (Cartegni
and Krainer, 2002) or creation of hnRNP A/B-dependent exonic splicing silencer
(Kashima and Manley, 2003). There are many other diseases causes by disruption of
splicing events in humans, thus SR proteins play an important role in maintaining
genome integrity.
Therefore, elucidating the roles of SR proteins in alternative splicingand other
post splicing events can provide a better understanding of many cellular functions of
these proteins. In this thesis, an effort has been made to identify cellular functions of
two such SR-like proteins Btf and TRAP150 in mRNA processing. My data have led to a
new hypothesis for regulation of genome integrity by SR proteins,very different from
what has already been described for how loss of other SR proteins alters pre-mRNA
splicing patterns and leads to disease. My data from Btf- or TRAP150-depleted cells
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instead point to altered transcript levels as a cause for mitotic defects and as a
mechanism for loss of genome integrity in human cells.

BCLAF1/ Btf and TRAP150/THRAP3
The gene coding for Bcl-2 associated transcription factor-1 (Btf or BCLAF1 or
KIAA0164) (Nagase et al.,1996) maps to chromosome 6q22-23 (Kasof et al., 1999;
Parsa et al., 1994). It was originallyshownto be involved in apoptotic pathways by
interacting with E1B 19K, a homologue of Bcl-2 by in-vitro studies (Kasof et al., 1999).
Overexpression of Btf caused apoptosis, which could be blocked by co-expression of
E1B 19K. Furthermore, the reduction or absence of Btf in several cell lines and the
ability of Btf to suppress E1A-mediated transformation suggested a potential role for Btf
as transcriptional repressor and tumor suppressor (Kasof et al., 1999). Interestingly, no
interaction was reported between Btf and the pro-apoptotic BCL-2 family member Bax.
Thus, it was not entirely clear whether the functions attributed to Btf were indeed
because of the physical association of Btf with these Bcl-2 family members or not. The
nuclear distribution of Btf in cells was redistributed to cytoplasm and nuclear envelope
following co-expression of E1B 19K or BCL-2. It was not determined if the interaction of
Btf and E1B 19K was necessary for the ability of these anti-apoptotic factors to
suppress the pro-apoptotic or transcriptional repression activities of Btf.
Btf induces p53 expressionin response to genotoxic stress (Liu et al., 2007).
Chromatin immunoprecipitation assays revealed a role for Btf in regulating thep53
expression at both RNA and protein level by interacting with protein kinase Cδ (Liu et
al., 2007). Protein kinase Cδ activates Btf and directs it to bind a core promoter element
in the TP53 gene (Liu et al., 2007). RNAi mediated depletion of Btf or inhibition of
protein kinase Cδ resulted in decreased expression of p53 at protein and transcript
level, although it was not clear if Btf is phosphorylated by protein kinase Cδ. Taken
together, these studies suggest a potential role of Btf in transcription and apoptosis but
the exact mechanism is still not clear.
Biochemical analysis and yeast two-hybrid screening revealed Btf as a binding
partner of emerin (Haraguchi et al., 2004). Emerin is an inner nuclear membrane protein
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found mutated in Emery-Dreifuss muscular dystrophy (EDMD). Two mutations that
cause EDMD disrupted the binding of emerin to Btf (Haraguchi et al., 2004). This study
suggested a role of Btf in EDMD but its biological mechanism is still unclear. Upon
induction of apoptosis, Btf redistributed to the nuclear envelope colocalizing with
emerin. But it is still unclear that this colocalization suggests a role for these proteins in
apoptosis or it is simply a consequence of death.
Btf knockout studies in mice suggest that homozygous mutation of Btf genes is
not embryonically lethal; however newborn mice die 24-48 hours after birth because of
various lung defects. These homozygous mice have runted size and appearance, often
with polydactyly of the right hind paw (McPherson et al., 2009). Microarray hybridization
experiments were done to compare the global mRNA expression of BCLAF1-deficient
versus wild type lungs. Statistical analysis revealed muscle contraction, kidney
formation and Wnt signalling as the major pathways being affected in BCLAF1-deficient
mice (Sarras et al., 2010).
Thyroid hormone receptor-associated protein 150/TRAP150/THRAP3 was
initially identified as a component of nuclear receptor TRAP/Mediator complex (Ito et al.,
1999; Rachez and Freedman, 2001). The TRAP/SMCC/Mediator complex is a
mammalian transcriptional regulatory complex of about 25 different polypeptides that
are phylogenetically conserved (Ito and Roeder, 2001). Thyroid hormone receptor (TR)associated proteins are thought to be involved in TR-activated transcription by
interacting with the general transcriptional machinery. Thus, the TRAP complex was
identified as a coactivator complex for many different types of transcriptional activators.
TRAP150 is expressed in high levels in skeletal muscle, heart, placenta, kidney, and
lungs, and at slightly lower levels in brain and liver (Ito et al., 2002).
Domain structure and subcellular localization of Btf and TRAP150
Btf is expressedin a wide variety of tissues including brain, heart, placenta, lung
kidney and pancreas, with highest expression in skeletal muscles (Kasof et al., 1999).
Two alternatively spliced isoforms of Btf are known – isoform 1 or Btf-L (long form) and
isoform 2 or Btf-S (short form). Isoform 1 is the most predominantly expressed isoform
of Btf. The isoform 2 or Btf-S has 49 amino acids deleted nearthe C-terminus (Δ49 as
21	
  
	
  
	
  

	
  
	
  

shown in Figure vi). In my thesis, I have been working with the long form of Btf, since
that is the predominant isoform found in cells. Btf and TRAP150 are non-classical SR
proteinsthat have a characteristic RS domain (repeated serine-arginine residues) at the
N-terminus (Figure vi; residues 1-148 in Btf; residues 1-165 in TRAP150), unlike
classical SR proteins that have a C-terminal RS domain.
Btf and TRAP150 were identified as potential nuclear speckle proteins, but still a
clear idea of their functions in the cell is unknown. The main goal of my thesis was to
elucidate the cellular functions of Btf and TRAP150, and to understand if Btf and
TRAP150 have distinct or redundant roles in mRNA metabolism. Immunolocalization
assays revealed Btf and TRAP150 as nuclear proteins localizing predominantly in a
nucleolasmic foci-like patternwith someoverlay with nuclear speckles (Figure 3). Both of
these proteins have similar localization patterns and share a high degree of similarity in
their sequence. Alignment of Btf and TRAP150 show 39% sequence identity and 66%
sequence similarity (Figure vii; Potabathula, D. 2009).
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Figure vi. Schematic diagram of various domains of Btf and TRAP150.
A. This figure shows schematic representation of various domains of Btf (920 amino
acids) and the region against which the monoclonal (blue) and polyclonal (orange)
antibodies have been generated in our laboratory. RS domain is present at the Nterminusof Btf (1-148) unlike other classical SR proteins that have it at the C-terminus.
No other functional motifs were identified in the sequence. Alternative splicing produces
two isoforms of Btf: Btfs (short form) and BtfL (long form). Btfslacks a 49 amino acid
sequence near the C-terminus.
B. The amino acid sequence of BtfL. The sequence in purple represents the RS domain
and in blue shows the sequence against which monoclonal (234-412 amino acids) and
in orange represents the sequence (469-485) against which polyclonal Btf antibodies
were generated (Paula Bubulya, unpublished data).
C. Schematic representation of various domains of TRAP150 (955 amino acids). Similar
to Btf, TRAP150 also has a RS domain at the N-terminus (1-165). No other domains
have been identified in TRAP150. Commercially available TRAP150 antibodies
wereused (Bethyl laboratories).
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Figure vii. A graphical representation of the alignment of Btf and TRAP150
(Potabathula, D., 2009)
Full-length amino acid alignment of TRAP150 and Btf was done using the SIM
alignment tool at www.expasy.org. This figure shows the graphical representation of the
alignment. The similarity scale at the top is the color code of % similarity. The resulting
alignment was viewed asLaLNView in BLAST search.
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(Alignment data and figure display were generated using www.expasy.org;Potabathula, D.,
2009).
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Association of Btfand TRAP150 with Ribonucleoprotein complexes (RNP)
Ribonucleoprotein (RNP) particles play critical roles in gene expression and
regulation (Wahl et al., 2009). These RNA-protein complexes assemble stepwise to
promote progression through co-transcriptional events of the RNAPII gene expression
pathway such as pre-mRNA 5’ capping, polyadenylation, splicing, exon junction
complex association and mRNA export. The structure and composition of these RNP
complexes is highly dynamic and their functions also vary. LC-MS/MS studies that
examined the composition of human mRNPs discovered the presence of Btf and
TRAP150 (Merz et al., 2007). The association of Btf with mRNPs was found to be capdependent while that of TRAP150 was cap-independent. 5’-m7G capping is done by
cap binding complex CBP80/CBP20. 5’ capping of nascent transcripts is an important
step as it marks the transcripts for further post-transcriptional modifications like splicing
and

mRNA

export

(Hasoda

et

al.,

2005;

Lewis

and

Izaurralde,

1997)

Immunoprecipitation assays showed Btf and TRAP150 in a complex with heterogenous
nuclear ribonucleoprotein A1 (hnRNP A1) (Sarras et al., 2010). hnRNP A1 associates
with pre-mRNAs in the nucleus and appears to influence pre-mRNA processing and
other steps of mRNA metabolism and transport. Immunolocalization and coimmunoprecipitation assays by the McPherson laboratory demonstrated that Btf colocalized and immunoprecipitated with the export factor TAP/NXF1 (Sarras et al., 2010).
TRAP150 associates with TAP/NXF1 and other exon-junction complex proteins and
helps in mRNA export and degradation (Lee et al., 2010). TAP/NXF1 is essential for the
transport of mature mRNPs across nuclear pore complexes into the cytoplasm. Also, Btf
and TRAP150 are components of the SNARP complex that influences the stability of
cyclin D1 transcripts (Bracken et al., 2008). All the members of this complex like SNIP1,
Ski-interacting protein (SkIP) and Pininwere shown to have some role in either splicing
or mRNA transport. Additionally, a recent study has confirmed the presence of Btf and
TRAP150 in the same complex with hnRNP A1, nucleolin, SNIP1 (Heyd and Lynch,
2010). Taken altogether, these studies indicate a potential role for Btf and TRAP150 in
pre-mRNA processing, but their specific role in these events remains unclear.
Moreover, whether Btf and TRAP150 functionsare distinct or redundant is not
addressed in those studies.
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Mitosis
Cells of a multicellular organism undergo cellular growth and division only at
appropriate times. This controlled process of cellular division is referred to as the "cell
cycle". Two major things are accomplished during the cell cycle: duplication of cellular
components and an equal distribution of components into two daughter cells. Two major
phases of the cell cycle are the growth phase called interphase and cellular division
phase called mitosis. Interphase is subdivided into G1, S and G2 phases. Mitosis is
subdivided into prophase, metaphase, anaphase, telophase and cytokinesis. Several
checkpoints throughout the cell cycle monitor that proper conditions are met before the
cell cycle can proceed to the next phase. G1 checkpoint in interphase occurs right after
G1 and before the onset of S phase to monitor whether proper growth conditions have
been met. The cell can exit the cell cycle at this point to an arrested stage called G0.
During mitosis, the spindle assembly checkpoint (SAC) ensures proper chromosome
segregation by monitoring proper alignment of chromosomes during metaphase. It
prevents anaphase onset until all chromosomes are properly attached to the spindle.
Any misregulation in these steps can lead to generating cells with more or less
chromosomes, thus introducing aneuploidy or cancer.
Spindle Assembly Checkpoint (SAC)
The spindle assembly checkpoint is a signaling cascade that arrests the cell
cycle in mitosis when even a single chromosome is not properly attached to the mitotic
spindle (Kops et al., 2008; Lengauer et al., 2004). The spindle assembly checkpoint is a
quality control mechanism that ensures proper chromosomal segregation and stops the
cell from entering anaphase until all chromosomes are properly aligned at the
metaphase plate. Improperly attached chromosomes activate the SAC, which in turn
stops the cell cycle by negatively regulating CDC20, thereby preventing the activation of
the anaphase promoting complex (APC) (Figure viii). SAC proteins responsible for
producing this "wait anaphase signal" include MAD2/MAD3, BUB3 and CDC20
(Sudakin et al., 2001). SAC proteins are also known as mitotic checkpoint proteins.
Other proteins involved in SAC known as chromosomal passenger proteins are MAD1,
BUB1,

Mps1,

Aurora

B,

INCENP,

Survivin,
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and

CENP-F.
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prometaphase, the spindle assembly checkpoint proteins along with CDC20 assemble
at the kinetochores before attachment to the spindle assembly. A single unattached
kinetochore can activate the SAC. The major role of SAC proteins is to ensure correct
kinetochore-microtubule attachments after which they dissembleand activate the
APC/C. Active APC/C-CDC20 mediates the ubiquitination and degradation of securin
and cyclin B, which in turn leads to separase activation, Cdk1 inactivation, and
chromosome segregation and mitotic exit. The spindle assembly checkpoint senses
unattached kinetochores and/or lack of tension on the microtubules (Nicklas, 1997).
Unattached kinetochores recruit a complex of checkpoint proteins, including Mad2 and
BubR1 that inhibits the actions of the APC (Shah and Cleveland, 2000).CENP-Edependent BubR1 autophosphorylation at unattached kinetochores is important for
activating the spindlecheckpoint to prevent single chromosome loss (Guo et al., 2012).
CENP-E is required for accurate chromosome congression at metaphase. It binds to
and regulates the mitotic checkpoint kinase BubR1 at kinetochores (Chan et al., 1999;
Mao et al., 2003). Localization of MAD2 and BubR1 at kinetochores depends on Aurora
B kinase activity. Aurora kinase family members include Aurora kinase A, B and C.
Aurora A peaks during G2/M phase of the cell cycle and is involved in centrosome
maturation and separation during early prophase. AuroraB has roles in histone H3
phosphorylation,

chromosomal

condensation,

chromosomal

alignment

on

the

metaphase plate, bi-polar centromere-microtubule attachments, spindle checkpoint and
cytokinesis (Fu et al., 2007; Jackson et al., 2007).
Another goal of my dissertation project was to elucidate the cellular functions of
Btf and TRAP150 in cell cycle progression through mitosis. The major question is
whether Btf and TRAP150 act as mitotic regulators, having roles in regulating the
alignment of chromosomes at metaphase plate or if they regulate the splicing of major
mitotic regualtors and thereby having an effect on cell cycle progresion through mitosis.
Also, it will be interesting to understand if both these proteins have synergistic or
redundant functions in mitosis. By understanding this, it will be interesting to understand
the role of SR-proteins roles in mitosis.
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Figure viii. The spindle checkpoint proteins (Jackson et al., 2007)
This figure shows all of the crucial regulators of the mitotic checkpoint at the
kinetochore. On each kinetochore, when the microtubules are captured and proper
tension is detected, the checkpoint is satisfied and MAD2 is released, providing the
biochemical signal to proceed to anaphase. An unattached kinetochore activates the
spindlecheckpoint proteins, thereby recruiting MAD2 to the unattached kinetochore.
MAD2 thensignals to other checkpoint proteins including BUB3, BubR1, Aurora B,
CENP-E and CDC20 to the unattached kinetochore forming a multi-protein complex.
This multi-protein complex inhibits APC/C and prevents mitosis from proceeding to
anaphase.
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(Jackson et al., 2007)
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Role of SR proteins in cell cycle regulation
During mitosis, nuclear speckles become diffusely distributed in the cytoplasm,
but in later stages of mitosis, they reassemble to form cytoplasmic structures called
mitotic interchromatin granules or MIGs (Ferreira et al., 1994; Prasanth et al., 2003).
The function of MIGs is still unknown. SR proteins such as SRSF1 (serine/arginine-rich
splicing factor 1; SF2/ASF) and SC35 have been demonstrated to play an important role
in maintaining genome stability (Li and Manley, 2005a; Li and Manley, 2005b; Xiao et
al., 2007). Genetic depletion of SRSF1in chicken DT40 cells and human HeLa cellsled
to formation of transcriptional R-loops and DNA rearrangements and caused G2/M cell
cycle arrest, suggesting that SRSF1may have a role in chromatin dynamics and
function(Li and Manley, 2005a). Similarly, in mouse embryonic fibroblasts, loss of
SC35resulted in G2/M cell cycle arrest and genomic instability (Xiao et al., 2007).
Thus, previous studies suggest an important role of SR proteins in cell cycle
regulation and thereby function in maintaining genome stability. Also, a recent study
suggests that Btf and TRAP150may also be involved in cell cycle regulation. Both
proteins were identified as constituents of the SNIP1/SkIP associated RNA processing
(SNARP) complex, interacting with SNIP1, SkIP and Pinin (Bracken et al., 2008). Btf
and TRAP150, being a part of this complex, influenced the RNA stability of Cyclin D1
gene. Cyclin D1 is the master regulator of G1-S transition in cell cycle progression.
Interestingly, Btf exhibiteda cell cycle dependent expression with higher protein levels in
early G1 phase, lower levels in S phase and increased expression in G2/M phase of the
cell cycle. In contrast, TRAP150 showed consistent expression levels throughout the
cell cycle. This suggests that Btf and TRAP150 might have distinct functions in mitosis.
Reversible protein phosphorylation is a key regulatory mechanism of mitotic
progression. The majority of cell cycle regulators are hyperphosphorylated. LC-MS/MS
studies done for global phosphoproteome analysis on cell extracts, eitherfrom
asynchronized cellsor nocadoazole-arrested cells at metaphase identified Btf
phosphopepetides only in nocadazole treated samples. Multiple phosphorylation sites in
Btf were identified during G1 or M phase of the cell cycle (Dephoure et al., 2008). In
another study, Btf and TRAP150 were identified as phosphoproteins in HeLa cell extract
(Beausoleil et al., 2004; Linding et al., 2007). Furthermore, in-vivo phosphorylation
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studies using purified human mitotic spindles and mass spectrometric analysis identified
seven phosphorylated sites in Btf - S222, S285, S290, S385, S512, S658 and T840
(Nousiainen et al., 2006). Taken together, these research findingssupport our
hypothesis of a role of Btf and TRAP150in mitosis. It is still unclear, how do two
homologous proteins have a similar role in cell cycle regulation. In this thesis, an effort
has been made to tease apart the functional differences between Btf and TRAP150, by
understanding their roles in different cell processes.
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Rationale and Hypothesis
Btf (Bcl-2 associated transcription factor) and TRAP150 (Thyroid Hormone
Receptor ssociated Protein of 150 kDa or THRAP3) are serine-arginine-rich (SR)
proteins that were identified in the proteomic analysis of nuclear speckles. The main
function of SR proteins is for splice-site selection during pre-mRNA splicing. Most newly
identified nuclear speckle proteins show colocalization with known splicing factors in
nuclear speckles, whereas Btf and TRAP150 show a more diffuse distribution or localize
to punctate foci in the nucleus with limited nuclear speckle enrichment. Btf and
TRAP150 were previously reported to associate with synthetic affinity-purified in vitro
spliced mRNPs, and also as a part of the spliceosome complex, suggesting they are
involved in pre-mRNA processing events. A recent report revealed that TRAP150
activates pre-mRNA splicing in-situ and promotes nuclear mRNA degradation. Because
TRAP150 and Btf are so similar to each other, and because their subnuclear
localization is very different from that of other proteins identified in nuclear speckles, we
aimed to better define their specific roles in mRNA processing events like splicing or
mRNA export. This leads to my hypothesis that Btf and/or TRAP150 are involved
in pre-mRNA processing.
Our preliminary studies revealed that upon depletion of Btf, metaphase defects
such as chromosomal misalignment were observed (Figure 33; results). Based on the
recent studies that show Btf and TRAP150 influencing the RNA stability of cyclin D1
gene (Bracken et al., 2008) and also being putative phosphoproteins, it suggests that
Btf and TRAP150 might have a potential role in mitosis. Btf has a cell cycle dependent
expression with higher protein levels in early G1 phase. By contrast, TRAP150
expression levels are not dependent on cell cycle. Taken altogether, Btf and TRAP150
might have a potential role in mitosis, but the mechanism still remains to be elucidated.
Thus, I hypothesize that Btf or TRAP150 have a role in regulating proper
alignment of chromosomes at metaphase and thus affect cell cycle progression
through mitosis.
The following aims were performed to test my hypotheses:
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Aim 1: To examine the role of Btf and/or TRAP150 in pre-mRNA processing.
Aim 1 investigated the function of Btf and TRAP150 in pre-mRNA processing events like
splicing or mRNA export. Localization studies were done to examine the recruitment of
Btf and TRAP150 at transcription sites in-situ, and to determine whether they colocalize
with other splicing or exon junction complex proteins at transcription sites. Also, the
experimental approaches addressed if Btf and TRAP150 have redundant or
compensatory functions.
Aim 2: To investigate the role of Btf or TRAP150 in mitotic progression.
Aim 2 examined a novel role of Btf and TRAP150 in regulation of chromosomal
alignment at the metaphase plate for proper cell cycle progression. Additionally, exon
array data showed cell cycle as the major pathway affected upon Btf or TRAP150
depletion in HeLa cells. This raised a question as to whether Btf or TRAP150 are cell
cycle regulators, or if they regulate the expression or splicing of major cell cycle
regulators and thereby affect the cell cycle progression through mitosis.
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CHAPTER 2
Materials and Methods
Plasmid constructs
The full-length Btf cDNA open reading frame (KIAA0164; Nagase et al., 1996)
was subcloned as a SpeI and BamHI into pEYFP-C1 with a modified multiple
cloningsites containing an XbaI site. Full- length TRAP150 cDNA (a gift from Robert
Roeder, Rockefeller University, New York) was subcloned as a KpnI + BamHI fragment
into pEYFP-C1. YFP-Magoh cDNAs were a kind gift from Catherine Tomasetto (Institute
of Genetics and Molecular and Cellular Biology, Université de Strasbourg, France).
pSV2-CFP-Lac repressor, pSV2-YFP-Lac repressor, pEYFP-MS2BP, and pTetON-YFP
were a gift from David Spector (Cold Spring Harbor Laboratory, Cold Spring Harbor,
NY). U2OS 2-6-3 cells stably expressing mcherry-LacI were a gift from Prasanth
Kananganattu (University of Illinois at Urbana-Champaign, IL).
Cell lines
U2OS 2-6-3 cells (Janicki et al., 2004) were a gift from David Spector (Cold
Spring Harbor Laboratory, New York). U2OS 2-6-3 cells stably expressing mcherry-LacI
were a gift from Prasanth Kannanganattu (University of Illinois at Urbana-Champaign,
IL). BTM HeLa cells were previously described (Sharma et al., 2011).
Antibodies
Affinity-purified rabbit polyclonal anti-Btf antibodies were generated at Covance
(Denver, PA). Polyclonal antiserum (WU10) was directed against the peptide
ERPSTTKDKHKEEDKNS located near the C-terminus of Btf. This peptide sequence is
not found in TRAP150. WU10 antibody labels punctate foci in the nucleoplasm of HeLa
cells (see Figure 1). Immunofluorescence labeling of Btf is significantly reduced
following treatment of the cells with siRNA oligos targeting Btf. WU10 recognizes a band
of approximately 150 kDa by immunoblot that migrates at the same position as Btf
detected by a commercially available anti-Btf antibody (1:1000; Bethyl, Cat. No. A300608A). TRAP150 antibody was purchased from Bethyl (1:1000; Cat. No. A300-956A).
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SRSF1 was detected with monoclonal anti-SRSF1/SF2/ASF antibody AK103 (1:2500;
provided by Adrian Krainer, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY).
EYFP signal did not survive RNA-FISH procedure and for those experiments it was
detected with monoclonal EGFP antibody (1:100; Clontech, Cat. No. 632375).
For cell cycle progression experiments the following antibodies were used.
Mouse anti-tubulin (1:2500 for IF or WB), mouse anti-B-actin (1:3000 for IF or WB),
human anti-ACA antibody (1:3000 for IF), mouse anti-CENP-E (1:100 for IF), rabbit antiCENP-F (1:1000 for IF), mouse anti-AURK-B (1:100 for IF and WB), mouse antiphospho-H3 antibody (1:100 for WB).
Cell Culture
U2OS 2-6-3, HeLa cells or BTM cells were grown on the coverslips in Dulbecco's
modified eagle medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS)
(Hyclone, Logan, UT) and 1% penicillin/streptomycin antibiotic. U2OS 2-6-3 cells were
grown in 10% Tet-approved serum. Cells were incubated at 37°C and 5% CO2. HeLa
cells stably expressing rat beta-tropomyosin minigene used was described previously
(Prasanth et al., 2003, Sharma et al., 2011). To inhibit RNA polymerase II transcription,
HeLa cells were incubated with alpha-amanitin (50 µg/ml, Sigma-Aldrich, St Louis, MO)
for 6 hours. For inhibition of RNA polymerase II transcription in U2OS cells, the cells
were transfected and plated on coverslips. After 2.5 - 3 hours (most of the cells attach),
the medium was changed with that containing alpha-amanitin (50µg/ml). 3 hours post
amanitin addition, 1 µl of dox (1µg/ml) was added to the cells in the same medium for
activation of the U2OS reporter locus. The cells were then processed for
immunolocalization studies 2.5 hours post dox addition.
Coverslip Preparation
Coverslips were cleaned thoroughly by washing in one part nitric acid and two
parts hydrochloric acid for 2 hours with occasional stirring. They were rinsed in distilled
water until the pH returned to 7.0. The coverslips were then stored in 70% ethanol and
flamed prior to use.
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Transfection
U2OS 2-6-3 cells were transfected as previously described (Janicki et al.,
2004)by electroporation method using a Gene Pulser II (BioRad, Hercules, CA) (170 V,
950 µF) to label different regions of the locus. 2 µg CFP/YFP-lacR plasmid was used to
label locus chromatin, 2 µg YFP-MS2BP plasmid was used to label MS2 stem loops in
reporter transcripts, and 2 µg of respective plasmids were used to express various
protein factors (rtTA, YFP-Btf, YFP-TRAP150, mCherry-SF2/ASF, and YFP-Magoh).
Three hours after transfection, the U2OS 2-6-3 gene locus was activated by addition of
doxycycline (1 µg/ml) to the culture medium. Cells were processed for microscopy 2.5
hours after doxycycline addition. HeLa cells or HeLa BTM cells were suspended in 200
µl of DMEM and transfected by electroporation with 2 µg of YFP-Btf, YFP-TRAP150 or
YFP-Magoh DNA along with 40 µg of sheared Salmon Sperm carrier DNA (250 V, 950
µF) in a 4 mm gap cuvette. After electroporation, 1 ml DMEM was added to the cuvette
and 200 µl of this suspension was seeded per coverslip for further analysis.
RNA Interference (RNAi)
RNAi was performed as previously described (Sharma et al., 2010). Briefly, HeLa
cells or HeLa BTM cells (1x105) were plated in antibiotic-free medium and after 24
hours siRNA mediated transfection was done using Oligofectamine (Invitrogen,
Carlsbad, CA) alone (mock) or mixed with a non-targeted siRNAs against luciferase (60
pmol; control; catalog no. D-001210-02; Dharmacon RNA Technologies) or with 60
pmoles

Btf

siRNA

duplexes

GAACAUAGUACUCGGCAAA;

[siGENOME
siGENOME2

1

(D-020734-01)
(D-020734-02)

target
target

sequence:
sequence:

GGAAUGAGACGACCUUAUG; Dharmacon RNA Technologies, Lafayette, CO] or 60
pmoles TRAP150 siRNA duplexes [siGENOME 1 (D-019907-01) target sequence:
GGUAUAAGCUCCGAGAUGAUU and siGENOME 4 (D-019907-04) target sequence:
GUUGAUCUCCGCCUUGAUAUU]. Son siRNA duplex sequences were used as
previously described (Sharma et al., 2011).

For double knockdown of Btf and

TRAP150, the cells were transfected with BtfSi1 oligos (60 pmoles) and TRAPSi4 (30
pmoles). To prevent TRAP150 upregulation upon Btf depletion, 0.86 pmoles of
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TRAPSi4 siRNA oligo was used along with 60 pmoles of BtfSi1 siRNA oligo. 72 hours
post-transfection the cells were harvested for further analysis.
RNA Sample Preparation
Total RNA extraction was performed according to the Qiagen RNAeasy (Qiagen) kit
protocols. Nuclear and cytoplasmic RNA extraction was performed according to the
cytoplasmic and nuclear purification kit protocol (catalog no. 21000; Norgen Biotek, ON,
Canada). Genomic DNA was removed from all total, nuclear and cytoplasmic RNA
samples using Turbo DNA-free kit (Ambion) according to the manufacturer's protocol.
Immunofluorescence
Indirect immunofluorescence was performed as described earlier (Sharma et al.,
2010). Briefly, the cells were grown on glass coverslips in a 6-well dish and harvested at
50-60% confluency. Cells were washed with phosphate buffered saline (1XPBS; 18.3
mM Sodium phosphate monobasic, 84.5 mM Sodium phosphate dibasic, 1.45 M
Sodium Chloride) and immediately fixed with 2% formaldehyde (freshly prepared from
paraformaldehyde (Electron microscopy sciences; in PBS) for 15 minutes at room
temperature. After three washes with 1XPBS, the cells were then permeabilized with
0.2% Triton X-100 (prepared in 1XPBS) for 5 minutes at room temperature. After three
washes with phosphate buffered saline with normal goat serum (PBS/NGS), the cells
were incubated in appropriate secondary antibodies conjugated with Texas Red or
FITC. DAPI was added to the final PBS wash to label DNA. Primary antibodies used
were Btf (WU10; 1:2500 or monoclonal Btf antisera added straight on cells), SF2/ASF
(1:2500), TRAP150 (1:1000, Bethyl catalog number A300-956A). After three washes
with phosphate buffered saline with 0.5% normal goat serum (PBS/0.5% NGS), the cells
were incubated in appropriate secondary antibodies conjugated with Texas Red, Cy5 or
FITC (1:500; Jackson Immunoresearch Lab). DNA was stained with DAPI (10µg/ml).
Finally,

the

coverslips

were

mounted

in

mounting

medium

phenylenediamine medium) and sealed with a clear nail polish.
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RNA Fluorescence In-situ Hybridization (RNA-FISH)
RNA-FISH was performed as described earlier (Prasanth et al., 2003; SaccoBubulya and Spector, 2002; Sharma et al., 2010; Sharma et al., 2011). Cells were fixed
with 2% formaldehyde (PFA) for 15 minutes at room temperature followed by three
washes with1XPBS, 5 minutes each. Extraction was carried out in cytoskeleton (CSK)
extraction buffer (10mM NaCl, 300mM Sucrose, 3 mM MgCl2, 10mM PIPES pH 6.8)
plus 0.5% Triton-X-100 and 5 mM VRC . Hybridization was carried out for 3 hours at
37°C using a hybridization mixture consisting of 2XSSC (Cat. no 9763; Ambion, Austin,
TX) containing 1 mg/ml yeast t-RNA, 10% dextran sulfate (w/v), 20% formamide and 20
ng/ul of RNA-FISH probes. Immunofluorescence following RNA-FISH was performed as
previously described (Sharma et al., 2010) with the exception that 0.5% bovine serum
albumin (0903; Amresco, Ohio) in RNase-free phosphate buffered saline (PBS) was
used as a blocking agent to maintain RNase-free conditions. Exogenous YFP-Btf, YFPTRAP150 or YFP-Magoh were transfected 48 hours prior to performing RNA-FISH
using electroporation. YFP tag was detected with monoclonal EGFP antibody (1:100;
Clontech) following RNA-FISH, monoclonal anti-SRSF1/SF2/ASF antibody AK103
(1:2500; provided by Adrian Krainer, Cold Spring Harbor Laboratory, Cold Spring
Harbor, NY). In situ hybridization to detect poly (A)+ RNA was performed as described
(Huang et al., 1994; Sacco-Bubulya and Spector, 2002; Prasanth et al., 2003). The
hybridization mixture consisted of 2XSSC containing 1 mg/ml yeast t-RNA, 10% dextran
sulfate (w/v), 25% formamide and 80 ng/ul of oligo-dT50 (catalog no. D6758-001;
Sigma). Hybridization was carried out at 42°C overnight. The next day, cells were
washed for 30 minutes in formamide solution at 42°C followed by one wash in 2XSSC
for 30 minutes at room temperature. The DNA was then stained with DAPI and the
coverslips were mounted on slides for microscopy.
Mounting Medium Preparation
Antifade P-phenylenediamine medium:
Aglass scintillation vial (20 ml) with a small stir bar inside was used (as PPD is light
sensitive). 10 mg of p-phenylydiamine was weighed on a mettler balance and added to
the vial along with 1 ml of 1XPBS.The vial was placed on stir plate and allowed to mix
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until PPD was completely dissolved. The medium should appear almost colorless to a
slight tint of yellow. If it is an intense yellow or orange color the PPD is most likely
contaminated and will have background staining. Using a 10 ml pipette, 9 ml of glycerol
was added to the vial. The pH of mounting medium was adjusted to 8.0-9.0 using
carbonate-bicarbonate buffer (An estimated volume required was between 0.5-1 ml). pH
paper of range 6.5-10 was used to check pH of the medium.. The mounting medium
was then aliquoted into smaller volumes and stored at -80°C.
Carbonate-bicarbonate Buffer: This buffer consisted of two solutions. Solution A
consists of 0.2M solution of anhydrous sodium carbonate (2.12 g/100ml) and solution B
consists of 0.2M solution of sodium bicarbonate (1.68g/100 ml). 4 ml of solution A and
46 ml of solution B was mixed together and the pH of the buffer would be around 9.2.
Each new preparation of mounting medium was tested on fixed and permeabilized cells
that were directly mounted without immunolabelling. Mitotic cells were observed to be
sure that chromosomes did not indicate fluorescent labeling in the FITC channel.
N-propyl gallate medium (for Cy5):
0.05 grams of n-Propyl gallate was mixed with 1 ml 1M Tris-Cl (pH 8.0) and 9 mls of
Glycerol (56-81-5; Polysciences Inc, Warringon, PA) in amber colored scintillation vials.
The vial was then kept in 60°C water bath for 10-15 min and stored at -20°C.
Microscopy
Z-stacks (0.2 µm intervals) spanning entire nuclei were acquired on a DeltaVision
RT using a 60X objective (1.4 numerical aperture; Olympus, Tokyo, Japan), and
deconvolved using softWoRx 2.50 software (Deltavision by Applied Precision,
Transfection Issaquah, WA). Raw images or deconvolved images were displayed as
volume projections. To evaluate the degree of colocalization, the Pearson correlation
coefficient was calculatedby the difference in signal intensities of pixel between different
fluorophores (CFP, YFP or mcherry) in the image stack using DV software. A Pearson
correlation coefficient ranges from -1 to 1, and a value greater than 0.5 defines strong
colocalization. To evaluate the extent of overlap between Btf, TRAP150 and other
factors on U2OS 2-6-3 reporter loci, the average Pearson correlation coefficient for 50
loci per coverslip was calculated using SoftWorx software.
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Cell Viability Assays and Flow Cytometry
HeLa cells transfected with control siRNA duplexes, two different sets of siRNA
duplexes against Btf (BtfSi1, BtfSi2), two different set of siRNA duplexes against
TRAP150 (TRAPSi1, TRAPSi4) or with BtfSi1 and TRAPSi4 (B1T4) for double depletion
studies were processed 72 hours post transfection for cell cycle analysis by flow
cytometry or Vi-Cell counts. The medium was collected and centrifuged to capture all
floating cells. The attached cells in culture dish were first washed with 1XPBS,
trypsinized for 2 minutes at 37°C then collected in the same tube with floating cells. For
Vi-Cell counts the cells were then transferred to Vi-Cell vials and put in Vi-Cell analyzer
(Beckmen Coulter, CA, USA) for cell viability counts. For Flow cytometry analysis, the
cells were then pelleted by centrifugation at 1500 RPM for 2 minutes at 4°C. The pellet
of cells was then resuspended in 200 µl of ice-cold 1XPBS. 1 ml of ice-cold ethanol was
added by slow vortexing to fix the cells. The cells were then placed overnight at -20º C.
The next day the cells were centrifuged at 1500 RPM for 5 minutes to remove ethanol.
The cells were then washed once with ice-cold 1XPBS at 4°C for 2 minutes. The
supernatant was discarded and cells were resuspended in 1 ml of 1XPBS with 1 µg of
RNAse. The cells were incubated at 37ºC for 30 min. After RNase treatment, cells were
centrifuged and the supernatant was discarded. Thecells were resuspended with 1X
PBS and 1 µl of propidium iodide (10µg/µl). Care was taken to protect the samples from
exposure to sunlight. The DNA content of the cells was analyzed by flow cytometry (BD
Accuri C6 Flow cytometer, BDBiosciences, CA, USA). The data was analyzed using
Accuri software.
Live Cell Microscopy
HeLa cells stably expressing H2B-YFP were used for live cell microscopy. 2X105
cells were plated on a 60 mm coverslip for siRNA transfection with either control
siGENOME2 targeting luciferase, Btf siGENOME1, TRAP150 siGENOME4 or Btf
siGENOME1 and TRAP siGENOME4. 72 hours post-transfection, the coverslip with
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cells was transferred to a live imaging chamber (FCS2; Bioptechs, Butler, PA), perfused
with L-15 medium (without phenol red) containing 20% fetal bovine serum and 5%
penicillin/streptomycinand placed into a 37oC environmental chamber on the stage of a
Delta Vision RT imaging system. Different stages of mitosis wereimaged by acquisition
of z-stacks through the entire cell every 3 minutes for at least 2-3 hours for samples
treated with BtfSi1 or TRAPSi4 and for 10 minutes for at least 3-4 hours for samples
treated with BT (BtfSi1 and TRAPSi4).
Assembly of Focht Chamber system 2 (FCS2): The FCS2 chamber with perfusion ports
was cleaned with 70% ethanol. Then a cleaned gasket (0.75 mm) was placed such that
it sat exactly on the perfusion ports. A microaqueduct slide was placed such that it sat
on top and locates on same perfusion ports. Another gasket (cleaned with 70% ethanol)
was placed on top of the microaqueduct slide. Two pieces of platinum cured silicone
translucent tubing (one short and one long; Cat no. 75-300-200, ThermoFisher
Scientific, Barrington, IL, USA) were attached to the chamber's perfusion ports. A 5 ml
syringe was attached with the L15 medium (preheated at 37°C) to the longer tubing.
Then the coverslip (1.5 mm thick, 40 mm diameter) with cells growing was placed on
top (cell side facing the microaqueduct slide). Later, the round stage adapter base
(preheated at 37°C) was applied and its outer ring was rotated so that the microaqeduct
slide, gaskets and coverslip were symmetrically locked down. The chamber was
perfused with prewarmed L15 medium from syringe attached such that a uniform wave
of medium was seen filling up the chamber. This was then immediately placed on a
stage adaptor (preheated at 37°C) for imaging.
Immunoblotting
Cells were extracted in Laemmli buffer (0.5M Tris, pH 6.8, 10% SDS, glycerol,
BME, 2.25 M DTT) and equal amounts of protein (30 µg of total protein) per sample
were applied to 7% SDS-PAGE, transferred to nitrocellulose membrane (200 mA; for 2
hours), blocked in PBS containing 0.1% Tween 20 and 5% nonfat dry milk and probed
with primary antibodies anti-Btf WU10 (1:1000), anti-TRAP150 (1:1000) or anti-β-actin
(Sigma-Aldrich; 1:10,000). Secondary antibodies, either horseradish peroxidase (HRP)conjugated donkey anti-mouse or HRP-conjugated donkey anti-rabbit IgG (Jackson
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ImmunoResearch Laboratories, Cat. Nos. 711-035-152 and 715-035-150), were used at
1:25,000. HRP was detected by using Pierce ECL Western blotting substrate (Thermo
Scientific, Cat. No. 32106).
PCR Analysis
Quantitative RT-PCR was performed using qScript One-Step SYBR Green qRT-PCR
kit, Low Rox (cat no. 95059; Quanta Biosciences). RT-PCR analysis of BTM transcripts
was done using primers against exon 5 (5'-CCAGGAAGCTGGTGATCCT-3' and 5'AGCCACCTCGGCTCTCTC-3'). For each RT-PCR reaction, 100 ng of total, nuclear or
cytoplasmic

RNA

was

used.

Primers

targeting

U2snRNA

(5'-

CATCGCTTCTCGGCCTTTTG-3' and 5'-TGGAGGTACTGCAATACCAGG-3') and S14
RNA (5'-GGCAGACCGAGATGAATCCTC-3' and 5'- CAGGTCCAGGGGTCTTGGTCC3') were used to validate the nuclear and cytoplasmic fractions of RNA respectively. The
qPCR results were analyzed using the comparative Ct method (Pfaffl, 2001). Total and
cytoplasmic

RNA

was

normalized

to

GAPDH

(primers

5'-

ATGTTCGTGATGGGTGTGAA-3' and 5'-GGTGCTAAGCAGTTGGTGGT-3'), whereas
the nuclear RNA was normalized to U2 snRNA.
Identification of genome wide transcription and splicing targets of Btf and
TRAP150
Five replicates of the Human Exon Array 1.0 ST were performed on RNAsamples
from Btf (using two differentsiRNA oligos against Btf - BtfSi1 and BtfSi2) and TRAP150depleted (using siRNA oligos against TRAPSi4) and control Luciferase oligo treated
HeLa cells. Btf and TRAP150 depletion was confirmedby SDS-PAGE. Quality of RNA
wasdetermined by microfluidic analysis, using the Agilent 2100 Bioanalyzer with anRNA
LabChip Kit (Agilent; CA). The RNA integrity number (RIN) of 9.1 was obtained to
ascertain that the RNA was free of contaminants such as protein, phenol, ethanol and
salts. Whole Transcript (WT) expression array kit (Ambion) was used togenerate
biotinylated sense strand DNA targets from the isolated RNA. The WTexpression kit
uses a reverse transcription priming method that specificallyprimes non-ribosomal RNA
from the samples, including both poly (A) and non-poly (A) mRNA. Primers that avoid
rRNA binding were designed by using aproprietary-oligonucleotide matching algorithm.
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These primer sequences providecomplete and unbiased coverage of the transcriptome
while significantly reducingthe priming of rRNA.100 ng of total RNA was used from each
sample and firststrand synthesis was performed by using first strand enzyme mix
(compositionproprietary) and buffer (composition proprietary) in the provided PCR tubes
(Ambion; WT expression kit). Samples were incubated for 1 hr at 25°C, 1 hour at 42°C,
then for at least 2 minutes at 4°C in a thermal cycler using the firststrandcDNA
synthesis protocol (Ambion; WT expression kit). This cDNA was stored overnight at 80ºC. The next day single stranded cDNA was converted todouble stranded DNA using
RNase H and DNA polymerase. Second strand enzymemix and buffer was added to the
first strand cDNA and the tubes were incubated for 1 hour at 16°C, then for 10 minutes
at 65°C, then for at least 2 minutes at 4°C in athermal cycler. Using the double stranded
cDNA library generated as a template, a cRNAlibrary was made by using T7 RNA
polymerase in an in-vitro transcription reaction. The in-vitro transcription enzyme mix
and buffers were added at room temperature to the double stranded cDNA library and it
was incubated for 16 hrsat 40ºC and then overnight at 4ºC. The cRNA was then purified
by adding 10µl of nucleotide binding beads and 50 µl of nucleotide binding buffer
concentrate to each reaction. After mixing the beads and buffer 60 µl of isopropyl
alcohol was addedto each reaction and incubated on a gently rocking shaker for 2min.
The beads are captured by placing on a magnetic stand and by aspirating the clear
supernatant carefully. The beads were then washed twice with nucleic acid wash
solution (composition proprietary) and each time the beads were collected at the bottom
by using a magnetic stand. The cRNA was then eluted byusing the pre-heated (55ºC)
elution buffer (composition proprietary). The cRNA was then placed on ice briefly and
then stored at -80ºC.The cRNA was quantified by using the nano-drop and by cRNA
sizedistribution using an Agilent 2100 Bioanalyzer, and an RNA 6000 Nano Kit
(PN5067-1511). 10µg of cRNA was used to synthesize the second cycle cDNA
(synthesis of sense strand cDNA by reverse transcription) with the help ofrandom
primers. The cRNA, and primers were incubated in a thermocycler for 5min at 70ºC,
then 5 min 25ºC and finally for 2 min at 4ºC, followed by addition ofthe second cycle
enzyme and buffer mix. This mixture was then incubated usinga thermocycler for 10 min
at 45ºC, then 90 min at 42ºC, followed by 10 min at 70ºC and 2 min at 4ºC. Once these
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steps were completed, the sample received2µl of RNAse H to digest the left over RNA
and was incubated for 45 min at 37ºC, and then 5 min at 95 ºC followed by 2 min at 4ºC
in a thermocycler. To purify the cDNA mix, 10µl of nucleotide binding beads and 50 µl of
nucleotide binding buffer concentrate were added to each reaction. After mixing the
beads and buffer 120 µl of ethanol was added to each reaction and they wereincubated
on a gently rocking shaker for 2 min. The beads were captured by placing on a
magnetic stand and by aspirating the clear supernatant carefully. The beads were then
washed twice with nucleic acid wash solution (compositionproprietary) and each time
the beads were collected at the bottom by using amagnetic shaker. The cDNA was then
eluted by using the pre-heated (55ºC) elution buffer (composition proprietary). The
cDNA was placed on ice briefly andthen stored at -80ºC. The quality of DNA was
analysed by using the nano-dropspectrophotometer (Thermo Scientific). This purified
sense strand cDNA has anincorporation of dUTP that is ready for fragmentation and
labeling using theAffymetrix GeneChip WT terminal labeling kit as described further.
The sense strand cDNA obtained as described above was subjected to acombination of
uracil DNA glycosylase (UDG) and apurinic/pyrimidinicendonuclease 1 (APE 1) that
specifically recognizes the unnatural dUTPresidues and breaks the DNA strand. 5.5 µg
of sense cDNA was used and 16.8µl of fragmentation mix was added and incubated at
37ºC for 60 min followed by 93ºC for 2 min and 4 ºC for 2 min in a thermocycler. 45 µl of
sample was then transferred to 0.2 ml strip tube and the rest was analysed on the
bioanalyser to confirm that the fragments obtained were 40-70 nt in length. The
fragmented cDNA was stored at -20ºC overnight. A master mix using the
5Xdeoxynucleotidyl transferase (TdT) buffer, TdT and DNA Labeling reagent was
prepared and 15 µl was added to 0.2 ml strip tubes containing the 45 µL of fragmented
single-stranded DNA. TdT is an Affymetrix® proprietary DNA labeling reagent that is
covalently linked to biotin. After adding the labeling mix the tubes were incubated for 60
min at 37ºC, followed by 10 min at 70ºC and then 2 minat 4ºC. A hybridization cocktail
was prepared by adding the fragmented and labeled DNA, DMSO, control
oligonucleotides, 20X eukaryotic hybridization controls, water and 2X hybridization mix
(proprietary composition). This cocktail was heated on a heat block for 5 min at 99ºC,
cooled to 45ºC for 5 min and centrifuged at full speed for a minute. This cocktail was
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then injected through thesepta in the Affymetrix GeneChip ST Array. The array was
then placed in a 45ºC hybridization oven, at 60 RPM for 17 hrs. Once hybridized on the
chip each sample goes through an automated washing, staining and scanning on the
fluidics station using Affimetrix protocolF5450_0007. The scan generates .cel files,
which were further analyzed by using the software programs described below.
Analysis of exon array data
In order to identify genes with differential gene expression between the groups
Btf siRNA1 and Btf siRNA2 or TRAP150 siRNA1 and TRAP150 siRNA4 compared to
control, we studied hybridizations on the Human Exon 1.0 ST array using mixed model
analysis of variance. The analysis was run on December 10, 2009 by CGR Computer
withXRAY (version 3.998) software, the Excel add-in from Biotique Systems Inc. (Burke,
2007). The 10 input CEL files were analyzed with the AffymetrixHumanExon1.0 ST
array to identify genes that were significantly differentially expressed or displayed
(Gardina et al., 2006; Huanget al., 2007; Clark et al., 2007) significant differential
alternative splicing between the groups of interest. The input files were assigned to 3
groups, control and Btf siRNA1 and Btf siRNA2 or control and TRAPsiRNA1 and
TRAPsiRNA4, and analyzed for differential gene expression and alternative splicing.
They were then analysed by Alt-Analyse, cross-platform application that allows us to
process microarray data and assess genome-wide change in transcript levels as well as
alternative splicing events. Alt-Analyse uses core exons to detect the changes
intranscription by using the "Detection Above Background" (DABG), and followsthe
splicing index algorithm (the log ratio of the exon intensities between samples and the
MIDAS algorithm uses the ANOVA model on the splicing index to predict alternative
splicing changes. A Benjamini-Hochberg correction is applied in this software and helps
in eliminating false positives that are usually obtainedduring the exon array analysis.
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CHAPTER 3
RESULTS
Aim 1: To examine the role of Btf and/or TRAP150 in pre-mRNA
processing.
Btf (Bcl-2 associated transcription factor) and TRAP150 (Thyroid Hormone Receptor
Associated Protein of 150 kDa or THRAP3) are serine-arginine-rich (SR) proteins
identified in the proteomic analysis of nuclear speckles (Saitoh et al., 2004). Btf and
TRAP150 have 39% sequence identity and 66% sequence similarity (Divya P, Scott B,
Paula B, unpublished data); however it is not clear if their functions completely overlap.
Both Btf and TRAP150 associate with affinity-purified in-vitro spliced mRNPs (Mertz et al.,
2007) and are a part of the spliceosome complex (Wahl et al., 2007), suggesting a role of
these proteins in pre-mRNA processing. Additionally, TRAP150 was shown to associate
with exon junction complex (EJC) proteins, activate pre-mRNA splicing and induce mRNA
degradation (Lee et al., 2010). Btf has also been shown in a complex with different premRNA processing proteins like hnRNP A1, nucleolin, SNIP, Pinin (Heyd and Lynch, 2010,
Haya Sarras et al., 2011). However, nothing is known about the spatial distribution of Btf
and TRAP150 in the nucleus. Thus, we wanted to study the role of both Btf and TRAP150
in pre-mRNA processing and whether these two proteins share similar or different
functions.
Preparation of specific Btf Antibody (WU10) and its Specificity
Antibodies specific to Btf were raised in rabbits (Covance, Denver, PA). To validate the
specificity of these antibodies, we examined the immunofluorescence localization of Btf
with affinity purified WU10 and the pre-immune bleeds (Figure 1). The pre-immune
bleeds from rabbit WU10 showed no specific labeling (Figure 1A e) as compared to the
affinity purified antibody WU10 specific to Btf that showed localization of Btf to
nucleoplasmic foci (Figure 1A a). A commercially available Btf antibody from Bethyl
laboratories was used as a control that showed similar localization pattern of Btf to
nucleoplasmic foci (Figure 1A c). DNA was stained with DAPI (Figure 1A b, d, f).
Immunoblots also showed that WU10 recognizes Btf at 150 kDa similar to Bethyl
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antibodies in HeLa cell extracts (Figure 1B lanes 2 and 3). Pre-immune bleeds showed
no labeling in immunoblots (Figure1B lane 1). Immunoprecipitation was performed to
identify if WU10 can pull down Btf in HeLa extracts (Figure 1C). Btf was effectively
pulled down by WU10 antibody, as indicated by the presence of Btf in the bead-bound
fractions of immunoprecipitates (Figure 1C lane 3) similar to the commercially available
Bethyl antibody (Figure 1C lane 7). Since, Btf is similar to another protein called
TRAP150, we next examined the specificity of our Btf antibody WU10. Immunoblot
analysis of HeLa extracts transfected with YFP-Btf and YFP-TRAP150 showed that
WU10 could recognize exogenous Btf (arrowhead) in YFP-Btf extracts (Figure 1D lane
1) as well as endogenous Btf (arrow) in YFP-Btf, YFP-TRAP, YFP-Emerin (used as a
control for immunoblot) and HeLa extracts. WU10 could not recognize exogenous
TRAP150 in YFP-TRAP150 extracts (Figure 1D lane 2), confirming that WU10 is
specific to Btf and does not recognize its homologue TRAP150. Similarly, commercially
availableTRAP150 antibody used recognized only exogenous TRAP150 in YFPTRAP150 extracts (Figure 1D lane 6) and endogenous TRAP150 in YFP-Btf extracts
(Figure 1D lane 5).

49	
  
	
  
	
  

	
  
	
  

Figure 1. WU10 Antibody Preparation and its Specificity.
A. HeLa cells were processed for immunolabeling with Btf antibody WU10 (a) or Bethyl
anti-Btf antibody (c). Preimmune serum was used as a negative control (e). DNA was
stained with DAPI (b, d and f). Scale bar = 5 µm.
B. Immunoblot of Btf in HeLa whole cell extracts using preimmune serum (lane 1),
WU10 (lane 2) or Bethyl anti-Btf antibody (lane 3). Anti-beta-actin was used to confirm
equal loading. Lines indicate molecular mass markers at 250, 150, 100, 50 and 37 kDa.
C. WU10 anti-Btf immunoblot shows Btf in the bound fraction of WU10 (lane 3) and
Bethyl (lane 7) immunoprecipitates. Lane A contains materials bound to beads following
preclearing of the input, Lane I is the equivalent of 10% input. B indicates bound fraction
and U indicates unbound fractions for each immunoprecipitate.
D.Immunoblot of HeLa whole cell extracts transiently transfected with YFP-Btf, YFPTRAP150 or YFP-Emerin (as a positive control for immunoblot). Both endogenous
(arrow head) and exogenous (arrow)were identified by using antibodies against Btf
(WU10; 1:1000) and TRAP150 (Bethyl lab; 1:1000) respectively. Our antibody WU10
showed reactivity against Btf but not its homologue, TRAP150.
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Endogenous and exogenous Btf and TRAP150 localized to nucleoplasmic foci,
showing some overlay with nuclear speckles.
To test my hypothesis that Btf and/or TRAP150 might have a role in mRNA
processing, we first looked at the subcellular localization of Btf and TRAP150 in HeLa
cells. Immunolocalization studies revealed that both Btf and TRAP150 had similar
localization pattern, predominantly found in small foci throughout the nucleus (Figure 2A
a-d and e-h) with some overlap (shown by arrows) with the splicing factors such as
SRSF1 (SF2/ASF) (Figure 2A b and f). The full-length Btf cDNA open reading frame
(Nagase et al., 1996) and full-length TRAP150 pCIN4 was a gift from Robert Roeder
(Rockefeller University, New York) were subcloned into pEYFP-C1 (see methods).
HeLa cells transfected with YFP-Btf and YFP-TRAP150 were immunolabeld with
SRSF1 to confirm the localization of YFP-Btf and YFP-TRAP150 in nucleoplasmic foci.
YFP-Btf and YFP-TRAP150 showed a localization pattern similar to that of endogenous
Btf, in nucleoplasmic foci (Figure 2B a-d and e-h). This localization pattern of Btf and
TRAP150 was similar in all cell lines examined. 	
  
Localization of Btf and TRAP150 is dependent on RNA Polymerase II activity.
Nuclear

speckles

are

highly

dynamic

structures.

SR

proteins

reside

predominantly in nuclear specklesand havean arginine-serine-rich (RS) domain.
Phosphorylation of serines within theRS domain releases SR proteins from their storage
site (nuclear speckles) and they are recruited to transcription sites (Sacco-Bubulya and
Spector, 2002). Since Btf and TRAP150 were both isolated in purified nucelar speckle
fractions (Mintz et al., 1999; Saitoh et al., 2004) and are non-classical SR proteins, we
tested whether their localization changes upon transcription inhibition like other SR
proteins. The punctate nuclear localization of Btf and TRAP150 reorganized to enlarged
rounded nuclear speckles upon inhibition of RNAP II with alpha-amanitin (Figure3,
panel a-d and i-l). This suggested that the localization pattern of Btf and TRAP150 in
nucleoplasmic foci is transcription-dependent.
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Figure 2. Endogenous and Exogenous Btf and TRAP150 localize to nucleoplasmic
foci and showedsome overlay with nuclear speckles in U2OS cells.
A.U2OS cells were immunolabeled with anti-Btf (WU10) and anti-TRAP150. SRSF1
was used as a marker for nuclear speckles. Arrows indicate limited areas of overlap
between SRSF1 and either Btf or TRAP150. DNA is stained with DAPI. Scale bar, 5µm.
B. HeLa cells were transiently transfected with YFP-Btf or YFP-TRAP150 and
immunolabeled for SRSF1 (marker for nuclear speckles). Localization of YFP-tagged
Btf or TRAP150 was similar to their endogenous counterparts in nucleoplasmic foci with
limited overlay with nuclear speckles (arrows). DNA is stained with DAPI. Scale bar,
5µm.
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Figure 3. Localization of TRAP150 and Btf is dependent on RNA Polymerase II
activity.
A. In the absence of alpha-amanitin, TRAP150 (e, arrow) localizes in nucleoplasmic
foci, shows some overlap with splicing factor U1-70K (f) in nuclear speckles, and
localizes to enlarged rounded speckles (a, arrow) after alpha-amanitin treatment similar
to U1-70K (b, arrow).
B. Btf (m, arrow) localizes in nucleoplasmic foci, shows some overlap with splicing
factor U1-70K (n) and localizes to enlarged rounded nuclear speckles (i, arrow) after
alpha-amanitin treatment similar to U1-70K (j, arrow). DNA was stained with DAPI.
Boxed regions in a, e, i and m are enlarged in insets. Scale bar = 5 µm.
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Btf and TRAP150 localize at active transcription sites in-situ.
The localization pattern of Btf and TRAP150 in nucleoplasmic foci resembles that
of Br-UTP-labeled nascent transcripts. However, we observed limited overlap between
Btf or TRAP150 foci with individual endogenous transcription sites labeled with Br-UTP
in HeLa cells. Thus, in order to detect these proteins at transcription sites we utilized
integrated reporter gene arrays that can be easily visualized by microscopy. Two
different reporter cell lines were used to determine if Btf and TRAP150 localize to active
transcription loci. We first used a HeLa cell line with stably integrated rat betatropomyosin reporter minigene (BTM) that is constitutively active and can be visualized
by RNA fluorescence in situ hybridization (FISH) as a single transcription locus in each
cell nucleus (Prasanth et al., 2003; Sharma et al., 2011). The beta-tropomyosin gene in
this reporter contains exons 5, 6, 7 and 8 (Figure 4A). Exons 5, 7 and 8 are constitutive
exons common to all mRNA that are expressed in skeletal muscles, whereas exon 6 is
an alternatively spliced exon expressed in fibroblasts as well as smooth muscle cells
(Helfman et al., 1986; Sacco-Bubulya and Spector, 2002). A 24-mer oligonucleotide
complementary to exon 5 of the reporter minigene pre-mRNA was conjugated with
TexasRed to detect the BTM transcripts (both spliced and unspliced) by fluorescence
in-situ hybridization (RNA-FISH). BTM HeLa cells were processed for localization of
BTM transcripts by RNA-FISH, followed by immunolabeling of splicing factor SRSF1
and either Btf or TRAP150. Both Btf and TRAP150 were detected at the BTM
transcription site along with SRSF1 (Figure 4B). However, the rRNA processing factor
fibrillarin and PML protein did not overlap with the transcription site (Figure 5). This
suggests a role for these proteins in pre-mRNA transcription or processing.
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Figure 4. Btf and TRAP150 localize at BTM transcription sitesin situ.
A. Schematic representation of the rat beta-tropomyosin (BTM) minigene that includes
genomic sequence from exon 5 through exon 8. Introns are represented as thin lines
connecting the exons.
B. HeLa cells stably expressing the rat BTM minigene were processed for RNA-FISH
localization of BTM reporter RNA (b, g) and immunofluorescence localization of SRSF1
(c, h) and either TRAP150 (a) or Btf (f). The arrows indicate the colocalization of Btf and
TRAP150 at the BTM reporter locus. DNA was stained with DAPI. Scale bar, 5 µm.
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Figure 5. Fibrillarin and PMLare not present at the BTMlocus.
Negative control experiment showing that although the BTM locus (a) is closely
adjacent to nucleoli, the rRNA processing factor fibrillarin (a-d). Merge of panels a and b
is shown in c. PML protein (f) is also not enriched on the BTM locus (e-f). Arrows
indicate BTM transcription site. Scale bar = 5 µm.
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Figure 6. Schematic representation of the YFP-Btf deletion mutants.
Full-length Btf (1-921) is diagramatically represented as black bars. The region from 1148 comprises of repeated serine-arginine sequences (RS domain). Thus, one mutant
construct was generated that had onlythe RS domain (a). Various C-terminal deletion
mutants were constructed such as YFP-Btf1-740 (b), YFP-Btf1-640 (c), YFP-Btf1-540
(d), YFP-Btf1-440 (e). Immunofluorescence data suggested the region 540-640
important for immunolocalization of Btf. Thus, another internal deletion mutant was
constructed from full-length YFP-Btf that lacks 540-640 region (YFP-Btfd540-640; f).
The diagram is not drawn to scale. The green circle at the N-terminus of each construct
represents pEYFP-C1.
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To map the regions in Btf important for recruitment to transcription sites, various
deletion mutants were prepared from full length YFP-Btf (as shown in Figure 6).
Immunolocalization studies were done on HeLa cells transiently transfected with these
constructs and immunolabeled with SRSF1 as a nuclear speckle marker. RS domain in
SR proteins is known to be a speckle targeting sequence. Btf, though having this
charateristic speckle targeting sequence, was not observed to be targeted to nuclear
speckles. Thus, a deletion mutant of YFP-Btf (YFP-Btf1-148) was made that had just
the RS domain to chek if this domain was functional in Btf. Immunolocalization studies
with this construct showed that it co-localized with SRSF1 to the nuclear speckles
(Figure 7 e-h). This suggests that the RS domain in Btf is both functional and sufficient
to localize Btf to the speckles. Further, C-terminal deletion mutants such as YFP-Btf1740 and YFP-Btf1-640 did not show any change in their localization pattern (Figure 7 ip) as they localized to nucleoplasmic foci like endogenous Btf. YFP-Btf1-540 showed a
remarkable change in the localization pattern (Figure 7 q-t). Cells transfected with YFPBtf1-540 showed predominant localization of Btf to nuclear speckles as it precisely
colocalized with SRSF1 (Figure 7 q and s). So this suggested that the region 540-640 in
Btf is important for its nuclear foci-like localization. Further, an internal deletion construct
was prepared that lacked this region 540-640 (YFP-BtfΔ540-640). As expected, this
construct also showed enrichment of Btf in nuclear speckles colocalizing with the
nuclear speckle marker SRSF1 (Figure 7 u-x). Subsequently, we examined which
region in Btf is essential for its localization to BTM transcription sites. BTM HeLa cells
were transiently transfected with the YFP-Btf deletion mutants that showed localization
of Btf in nuclear speckles (YFP-Btf1-148, YFP-BtfΔ540-640, YFP-BtfΔ616-632) and
processed for localization of BTM transcripts by RNA-FISH, followed by immunolabeling
ofGFP (Figure 8). All YFP-Btf deletion constructs localized to the BTM transcription site
(Figure 8 a-p). This suggested that the RS domain in Btf (C-terminal deletion mutant
YFP-Btf1-148) was sufficient for the localization of Btf to BTM transcription site.
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Figure 7. The region 540-640 in full-length YFP-Btf regulates the localization of
YFP-Btf in nucleoplasmic foci in HeLa cells.
HeLa cells were transcientlytransfected with various YFP-Btf deletion mutants: YFPBtfFL (a-d), YFP-Btf1-148 (e-h), YFP-Btf1-740 (i-l), YFP-Btf1-640 (m-p), YFP-Btf1-540
(q-t), YFP-BtfΔ540-640 (u-x), and immunolabelled for the nuclear speckle marker
SRSF1. DNA was stained with DAPI. Btf colocalized with SRSF1 at the nuclear
speckles upon deletion of the region 540-640 from full-length YFP-Btf. Thus, this region
is essential for its localization in nucleoplasmic foci.	
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Figure 8. The RS domain is sufficient forBtf localization at BTM transcription
sites.
HeLa BTM reporter cells were transietly transfected with YFP-Btf (a-d), YFP-Btf1-148
(e-h), YFP-BtfΔ540-640 (i-l) and YFP-BtfΔ616-632 (m-p). Arrows indicate BTM
transcription sites. The constructthat containsonly the RS domain (YFP-Btf1-148) was
sufficient to localize YFP-Btf to BTM reporter locus (shown by arrows). DNA was
stained with DAPI. Scale bar, 5 µm.
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Localization of Btf and TRAP150 at transcription sites is dependent on RNA
PolymeraselI activity.
To examine whether the localization of Btf and TRAP150 is transcriptiondependent, we used the U2OS 2-6-3 transgene array, an inducible reporter system that
allows simultaneous visualization of a chromatin locus, its reporter RNA transcripts and
its reporter protein (Figure 9; Janicki et al., 2004). This system utilizes the lac
repressor/operator interaction to visualize the chromatin at the locus, tetracycline
response elements (TRE) and activator protein (TetON) to experimentally regulate
transcription, and YFP-tagged MS2 bacteriophage coat protein to label RNA stem loop
structures in the transcribed RNA. Additionally, the reporter mRNA encodes for a CFP
protein with a peroxisomal targeting signal, and its appearance in cytoplasmic
peroxisomes (Figure 9B panel d) confirms that all post-transcriptional events have
occurred properly. There are about 200 copies of this transgene array stably integrated
in U2OS cells. Transcripts can be detected at this locus (YFP-MS2BP, Figure 9B panel
c) almost immediately after induction, and the locus chromatin completely decondenses
within 2 hours of doxycycline addition.Reporter locus can be observed in two different
states: the ‘open/transcriptionally active’ (Figure 9B panel b) or ‘closed/transcriptionally
inactive’ (Figure 9B panel a) chromatin state of the locus. The spatiotemporal
localization of gene regulators can be examined in U2OS 2-6-3 cells during gene
activation or repression. Upon activation of this gene locus, transcription and pre-mRNA
processing machinery such as RNA polymerase II, splicing factors, EJC proteins, 5’capping and polyadenylation factors get recruited to the transcription site (Janicki et al.,
2004). Immunolocalization studies revealed that both endogenous Btf and TRAP150
localized to the transcriptionally active locus (Figure 10 a-d, i-l) and not to the inactive
locus (Figure 10 e-h and m-p). Cells were scored according to their conformation of the
loci (open, partially open or closed) in the presence and absence of dox and the
recruitment of Btf and TRAP150 at those loci was estimated (Potabathula, D., 2009). It
was observed that 61% of cells with open loci were associated with Btf while only 7%of
cells with close loci were associated with Btf. Also, around 64.3% of cells with open loci
and 6.6% of cells with closed locus were associated with TRAP150 (Potabathula, D.,
2009). This confirmed that Btf and TRAP150 are associated with most of the
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transcriptionally active locus and not with the inactive locus, consistent with RNAPIIdependent accumulation at these transcription sites. We next asked if this enrichment of
Btf and TRAP150 at active locus requires synthesis of nascent transcripts. Treatment of
U2OS 2-6-3 reporter cells with alpha-amanitin (50 µg/ml) prevented transcript
production in the presence of doxycycline as evident by absence of MS2-binding protein
enrichment at the transciption site (Figure 11 f and n). In amanitin-treated cells, neither
TRAP150 (Figure 11A) nor Btf (Figure 11B) was found at the activated transcription
array (Figure 11 e-h and m-p). Btf and TRAP150 accumulated in speckles following
amanitin treatment, and in some cases, speckles were in close proximity with the locus.
Control cells that were induced in parallel but not treated with amanitin showed Btf and
TRAP150 at the active transcription site (Figure 11 a-d and i-l).
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Figure 9.U2OS 2-6-3 cells allow visualization of gene expression in living cells.
A. Schematic representation of U2OS 2-6-3 inducible reporter array (Janicki et al.,
2004).
B.This system utilizes the lac repressor/operator interaction to visualize chromatin at the
reporter locus (a, b), tetracycline response elements and activator protein (TetON) to
experimentally regulate transcription, and YFP-tagged MS2 bacteriophage coat protein
to label RNA stem loop structures in the transcribed RNA (c). The reporter mRNA
encodes for CFP tagged with a peroxisomal targeting signal (d), and its appearance in
cytoplasmic peroxisomes confirms that all post-transcriptional events have occurred
properly. Approximately 200 copies of the depicted plasmid are integrated in a
euchromatic region of chromosome 1 in these cells (Janicki et al., 2004).
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Figure 10. Btf and TRAP150 localize at U2OS 2-6-3 reporter locus transcription
sites in situ.
U2OS 2-6-3 cells transfected with YFP-LacR and pTet-ON were left uninduced (e-h, mp) or induced to activate the reporter (+Dox; a-d, i-l). At 2.5 hours after dox addition, the
cells were processed for immunofluorescence localization of TRAP150 (a-h) or Btf (i-p).
DNA was stained with DAPI. Boxed regions are enlarged in insets. Scale bar = 5 µm.
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Figure 11. Localization of Btf and TRAP150 at a transcription site is dependent on
RNA Polymerase II activity.
U2OS 2-6-3 cells were transiently transfected with CFP-LacR, pTET-ON and YFPMS2BP. Dox (1 mg/ml) was added to the medium to activate locus transcription and the
cells were fixed 2.5 hours after dox addition. Alpha-amanitin (50 µg/ml) was added to
the medium for 6 hours post-transfection and the cells were then immunolabelled for Btf
and TRAP150.
A.

In the absence of amanitin, TRAP150 (c) localized at the active locus. In the

presence of amanitin, the locus was decondensed (e); however, MS2BP accumulation
in speckles rather than at the active locus indicated that no transcripts were produced
under these conditions (f), and TRAP150 (g) was absent.
B. In the absence of amanitin, Btf (k) localized at the active locus. In the presence of
amanitin, the locus was decondensed (m); however, MS2BP accumulation in speckles
rather than at the active locus indicated that no transcripts were produced under these
conditions (n), and Btf (o) was absent. Boxed regions in a, e, i and m are enlarged in
insets. Scale bar = 5 µm.
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Co-localization of Btf and TRAP150 with other RNA processing factors at the
active locus.
We used the U2OS 2-6-3 cells to examine the extent of overlap between Btf or
TRAP150 and well-characterized RNA processing proteins in order to identify the most
likely role for TRAP150 and Btf in gene expression. Since Btf and TRAP150 have been
previously reported to have a role in transcription (Kasof et al., 1998; Ito et al., 2002),
we looked for the extent of their colocalization with transcriptional activator rtTA. There
was no co-localization observed with endogenous Btf (Figure 12A, a-d) and TRAP150
(Figure12A, e-h) with both the transcriptional activator rtTA or the lac repressor
associated with the operator sequences (Figure 12). Pearson correlation coefficients
also indicated minimal overlap (0.02 for rtTA and TRAP150, Figure 12B and 0.35 for
rtTA and Btf, Figure 12C). This argues that neither of these proteins is a bona-fide
transcription factor for activation of this locus, and pressed us toward further examining
other roles in pre-mRNA processing as would be expected for Btf and TRAP150 since
they are both SR proteins that interact with other RNA processing factors (Spector and
Lamond; Sarras et al., 2010).
Btf and TRAP150 co-immunoprecipitated with exon junction complex (EJC)
proteins (Lee et al., 2010). However, it is not yet known if TRAP150 and Btf and the
other proteins within these complexes all colocalize at transcription sites, or if such
complexes are limited to nuclear speckles where all of these components have been
identified (Mintz et al., 1999; Saitoh et al., 2004). So further, we examined the extent of
colocalization of Btf and TRAP150 with other known pre-mRNA processing proteins
such as splicing factors and exon junction complex proteins at the active U2OS 2-6-3
reporter locus. For this study, we first examined the colocalization of Btf and TRAP150
with reporter transcripts. In order to label the reporter transcripts we expressed the MS2
stem loop binding protein fused with YFP (YFP-MS2BP). YFP-MS2BP was expressed
along with CFP-LacR in U2OS 2-6-3 cells and cells were counted for colocalization of
the reporter transcripts (labeled with YFP-MS2BP) and the locus (labeled with CFPLacR).
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Figure 12. Btf and TRAP150 do not colocalize with transcriptional activator at the
U2OS 2-6-3 reporter locus.
A.U2OS 2-6-3 cells were transiently transfected with pTetON-YFP and CFP-LacR and
seeded on coverslips. Doxycycline was added to the medium 3 hours post transfection.
After 2.5 hour of doxycycline addition, cells were processed for immunolabeling of
endogenous Btf or TRAP150. 100% of the cells counted showed that Btf (a) or
TRAP150 (e) accumulate at the active locus (panel b and f) but does not colocalize with
the transcriptional activator encoded by pTetON (rtTA; panels c and g). Boxed regions
in b and f are enlarged in insets. Scale bar, 5 µm.
B. Pearson Correlation Coefficient for the activator rtTA and TRAP150.
C. Pearson Correlation Coefficient for the activator rtTA and TRAP150.
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I observed that 100% of the cells showed overlap between the brightest region of
YFP-MS2 and CFP-LacR. Thus, the brightest region occupied by MS2BP is an accurate
way to label active U2OS 2-6-3 reporter loci by microscopy, as the area of highest YFPMS2BP accumulation was always in the nuclear region labeled by Lac repressor
(Figure13A). Btf and TRAP150 were overexpressed as CFP-tagged proteins along with
YFP-MS2 binding protein and these cells were then immunolabeled for SRSF1 (Figure
14). We noted a striking overlap of Btf and TRAP150 that consistently showed an
identical labeling pattern at the active locus, and had a higher Pearson correlation
coefficient (PCC of 0.87), slightly more than that observed for reporter RNA/Btf overlap
or reporter RNA/TRAP150 overlap (Figure 14B). SRSF1 was used as a positive control
andshowed significant colocalization (PCC of 0.75) with YFP-MS2BP-labeled reporter
transcripts (Figure 13B and 13C) as expected for this reporter system (Janicki et al.,
2004).
To map the region in Btf essential for its colocalization with TRAP150 at this
transcriptionally active U2OS 2-6-3 reporter locus, the same YFP-Btf deletion constructs
was used as described earlier (Figure 6) and examined if expression of any of these
constructs changes the colocalization pattern of Btf and TRAP150 at the active locus.
First, we examined if the YFP-Btf constructs show the same localization pattern in
parental U2OS cells (Figure 15) as seen in HeLa cells (Figure 7). Another deletion
construct YFP-BtfΔ616-638 showed colocalization of Btf and SRSF1 in nuclear speckles
(Figure 15 q-t). The immunolocalization pattern of all these YFP-Btf constructs was
similar in both the cell lines (Figure 15). U2OS 2-6-3 cells stably expressing
mcherryLacI were transiently transfected with YFP-Btf constructs and CFP-TRAP150 to
study the colocalization of both the proteins at active locus. All the YFP-Btf constructs
colocalized precisely with CFP-TRAP150 at the active locus (Figure 16 a-x).
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Figure 13. SRSF1 localization on the transcriptionally active U2OS 2-6-3 array.
A. YFP-MS2 labeling is a reliable means of locating the U2OS 2-6-3 array within the
nucleus. Out of 50 cells counted, all showed overlap between the brightest YFP-MS2
region and CFP-LacR.
B.Immunoocalization of U2OS 2-6-3 reporter locus with transiently transfected CFPLacR (to visualize the locus) showing overlap of endogenous SRSF1 and reporter RNA
(indirectly detected by YFP-MS2BP).
C.Pearson Coorelation Coefficient for YFP-MS2 and SRSF1.
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Figure14. Btf and TRAP150 colocalize with each other extensively at transcription
sites in-situ.
A. U2OS 2-6-3 cells expressing pTetON, YFP-MS2BP (panel a), and CFP-TRAP150
(panel b) were processed for immunolabeling of Btf (panel c). 100% of the cells counted
showed that Btf and TRAP150 overlap extensively at the active locus.
B. Plot and PCC calculated for CFP-TRAP150/endogenous Btf compared to either
protein with YFP-MS2BP (reporter RNA).
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Figure 15. Localization of YFP-Btf deletion mutants is similarin U2OS cells to
HeLa cells.
U2OS cells were transiently transfected with YFP-BtfL (a-d), YFP-Btf1-148 (e-h), YFPBtf1-540 (i-l), YFP-BtfΔ540-640 (m-p), YFP-BtfΔ616-638 (q-t) and immunolabelled for
SRSF1. YFP-Btfshowed a nucleoplasmic foci-like pattern and the other deletion
mutants were found enriched at nuclear speckles colocalizing with the splicing factor
SRSF1, similar to what was observed earlier in HeLa cells. DNA was stained with DAPI.
Scale bar, 5 µm.
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Figure 16. YFP-Btf deletion mutants co-localize with TRAP150 at active U2OS 2-63 transcription sites.
U2OS 2-6-3 cells stably expressing mcherryLacI were transiently transfected with YFPBtf (a-d), YFP-Btf1-148 (e-h), YFP-Btf148-920 (i-l), YFP-Btf 1-640 (m-p), YFP-Btfd540640 (q-t), YFP-Btfd616-639 (u-x) along with CFP-TRAP150. Arrows indicates U2OS 26-3 reporter locus.
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Next we examined the colocalization of Btf and TRAP150 with the splicing factor
SRSF1 at the active locus and reporter transcripts. CFP-tagged Btf and TRAP150 were
transiently expressed along with mcherry SF2 (SRSF1) and YFP-MS2 (labels the
reporter transcripts) in U2OS 2-6-3 cells in the presence of dox to activate the locus. Btf
and SRSF1 showed significant colocalization (with very high PCC of 0.91; Figure 17A ad, 17B) with reporter transcripts. There was limited colocalization seen with the reporter
transcripts and Btf (Figure 17C). Similarly, TRAP150 also colocalized significantly with
the splicing factor SRSF1 (with very high PCC of 0.87; Figure 18A a-d. 18C). There was
limited colocalization seen with the reporter transcripts and TRAP150 (Figure 18D).
Next, we examined if CFP-tagged Btf/TRAP150 showed the same significant
colocalization with SRSF1 at the active locus marked by CFP-LacR (Figure 19). There
was a similar significant colocalization observed between Btf/TRAP150 with SRSF1
(Figure 19A, B and C). We then examined colocalization of Btf/TRAP150 with the exon
junction complex protein Magoh at this active locus. CFP-tagged Btf or TRAP150 were
transiently expressed along with YFP-Magoh in U2OS 2-6-3 cells stably expressing
mcherry LacR. All of the subregions within the activated reporter locus that were
occupied by the EJC protein Magoh colocalized precisely with Btf (Figure 20A a-d,
20B). A sample treated in parallel showed precise overlap of Magoh with TRAP150
(Figure 20A e-h, 20C). PCC showed that the extent of overlap with Btf or TRAP150 was
higher with Magoh than with SRSF1 (Figure19 B-C compared with figure 20 B-C). We
also examined colocalization of Btf or TRAP150 with endogenous SRSF1 (Figure 21A
a-n) and YFP-Magoh (Figure 21B a-n) at consitutively active BTM transcription sites
labeled by e5 probe. To determine the physiological relevance of colocalization of Btf
and TRAP150 with each other, as well as with the EJC protein Magoh, we examined if
TRAP150 and/or Magoh co-immunoprecipitate with Btf in extracts from 293 cells
transfected

with

YFP-TRAP150

and

YFP-Magoh.

Btf

complexes

were

immunoprecipitated using our anti-Btf antibody WU10 and separated by SDS-PAGE.
YFP-TRAP150 and YFP-Magoh were found in the anti-Btf immunoprecipitates (Figure
22).
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Figure 17. Btf co-localize with SRSF1 at active transcription sites in-situ.
A. U2OS 2-6-3 cells transiently transfected with YFP-MS2, pTetON, mcherrySF2 and
CFP-Btf were fixed 2.5 hours after doxycycline addition (a-d). 100% of the cells counted
showed co-localization of Btf with SRSF1 at the active locus.
B. Plot and PCC calculated for CFP- Btf compared to SF2/ASF (SRSF1). PCC shows
significantly high colocalizaiton between Btf and SRSF1.
C. Plot and PCC calculated for CFP- Btf compared to reporter RNA (YFP-MS2). PCC
shows a moderate colocalization between reporter RNA and Btf
D. Plot and PCC calculated for reporter RNA compared to SF2/ASF (SRSF1). PCC
shows a moderate colocalization
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Figure 18. TRAP150 co-localize with SRSF1 at active transcription sites in-situ.
A. U2OS 2-6-3 cells transiently transfected with YFP-MS2, pTetON, mcherrySF2 and
CFP-TRAP150 were fixed 2.5 hours after doxycycline addition (a-d). 100% of the cells
counted showed co-localization of TRAP150 with SRSF1 at the active locus.
B. Plot and PCC calculated for CFP-TRAP150 compared to SF2/ASF (SRSF1). PCC
shows significantly high co-localization between TRAP150 and SRSF1.
C. Plot and PCC calculated for CFP-TRAP150 compared to reporter RNA (YFP-MS2).
PCC shows a moderate co-localization between reporter RNA and TRAP150.
D. Plot and PCC calculated for reporter RNA compared to SF2/ASF (SRSF1). PCC
shows a moderate co-localization between SRSF1 and reporter RNA.
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Figure 19. Btf and TRAP150 co-localize with the splicing factor SRSF1 at the
active U2OS 2-6-3 reporter locus.
A. U2OS 2-6-3 cells transiently transfected with YFP-lacR, pTetON and CFP-Btf or
CFP-TRAP150 were fixed 2.5 hours after doxycycline addition (a-h) and
immunolabelled for SRSF1. 100% of the cells counted showed co-localization of
Btf/TRAP150 with SRSF1 at the active locus.
B. Plot and PCC calculated for CFP-Btf compared to either SRSF1 or YFP-LacR.
C. Plot and PCC calculated for CFP-TRAP150 compared to either SRSF1 or YFP-LacR.
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Figure 20. Btf and TRAP150 colocalize extensively with the exon junction
complex component Magoh.
A. U2OS 2-6-3 cells stably expressing mcherry-LacI (a, e) were transfected with YFPMagoh (c, g) and either CFP-Btf (b) or CFP-TRAP150 (f). 100% of the cells counted
showed remarkable co-localization of Btf and TRAP150 with Magoh at the active locus.
Boxed regions in a, e, b, f, c, g, d and h are enlarged in insets. Scale bar, 5 µm.
B. PCC calculated for Btf and Magoh showing significantly high values confirming their
co-localization.
C. PCC calculated for TRAP150 and Magoh showing significantly high values
confirming their co-localization.
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Figure 21. Btf and TRAP150 co-localize with the splicing factor SRSF1 and Magoh
at a constitutively active rat beta-tropomyosin minigene locus.
A.Endogenous TRAP150 and Btf co-localized with SRSF1at a constitutively active rat βtropomyosin reporter locus (BTM). BTM HeLa cells stably expressing rat βtropomyosinminigene locus were processed for RNA-FISH localization of reporter RNA
(panels b and i) and immunofluorescence localization of TRAP150 and Btf (panels a
and h respectively) and SRSF1 (panels c and j).
B.Endogenous TRAP150 and Btf co-localizes with Magoh to a constitutively active rat
β-tropomyosin reporter locus (BTM). BTM HeLa cells stably expressing rat βtropomyosin minigene locus were transiently trasfected wiht YFP-Magoh and processed
for RNA-FISH localization of reporter RNA (panels aand h) and immunofluorescence
localization of TRAP150 and Btf (panels c and j respectively) and YFP-Magoh (panels b
and i).
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Figure 22. TRAP150 and Magoh co-immunoprecipitate with Btf.
Immunoblots show co-immunoprecipitation of YFP-TRAP150 and YFP-Magoh with
endogenous Btf. 293 cells were transiently transfected with 2 µg of YFP-TRAP150 and
YFP-Magoh plasmids followed by immunoprecipitation with Btf antibody (WU10) or
preimmune serum as negative control. Immunoprecipitates without antibody served as a
control to see non-specific binding of the proteins to beads. PCB contains materials
bound to beads following preclearing of the input. Immunoprecipitates dissolved in
Laemmli buffer were subjected to 8% SDS-PAGE and immunoblotted with polyclonal Btf
antibody and monoclonal GFP antibody. PCB - Precleared Beads, Lane I is the
equivalent of 10% input. B indicates bound fraction and U indicates unbound fractions
for each immunoprecipitate.
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Figure 23. Immunoprecipitation of Btf to identify endogenous interactingpartners.
A. HeLa whole cell nuclear extracts were used for immunoprecipitation with Btf antibody
(WU10, lane 2), WU10 preimmune as a negative control (lane 3). Immunoprecipitates
without antibody served as a control to see non-specific binding of the proteins to
beads. PCB contains materials bound to beads following preclearing of the input.
Immunoprecipitates dissolved in Laemmli buffer were subjected to 4-12% gradient SDSPAGE and immunoblotted with polyclonal Btf antibody.
B. A sister SDS-PAGE was run and the immunoprecipitates (Bound and Unbound
fraction) were analyzed by immunoblotting with anti-Btf (WU10). Btf was seen at 150 KD
shown by red arrow (lane3) showing Btf in the bound fraction of WU10
immunoprecipitates and input (compare lane 2 and 3). The negative control preimmune
bound fraction (lane 4) did not have Btf. PCB - Precleared Beads, Lane I is the
equivalent of 10% input. B indicates bound fraction and U indicates unbound fractions
for each immunoprecipitate.
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Taken together with our in situ data, our biochemical data and data from other
groups suggests that Btf and TRAP150 associate with nascent transcripts along with
other mRNA processing factors, most likely as components of the EJC. In addition the
U2OS 2-6-3 locus has a unique organization that allows many different gene expression
steps, from transcription to mRNP assembly, to be visualized simultaneously in
separate compartments. We demonstrate here that the extent of colocalization obtained
by mapping proteins onto these compartments of the U2OS 2-6-3 reporter array can be
useful for nailing down the most likely gene expression function of uncharacterized
proteins. Further, to identify more interacting partners of Btf, Btf immunoprecipitates
were run on SDS-PAGE and silver staining was done (Figure 23A). A sister immunoblot
was done that showed efficient pull down of Btf by WU10 in the bound fraction of
immunoprecipitates (Figure 23B lane 3). Different specific bands in WU10 bound
fractions (Figure 23A lane 2, 1-7) were cut and sent for MALDI/TOF analysis. This will
help in future to identify putative interacting proteins of Btf.
Role of Btf and TRAP150 in pre-mRNA splicing.
To investigate if Btf and TRAP150 havea role in splicing, I examined the
processing of beta-tropomyosin transcripts in BTM HeLa cells following depletion of Btf
or TRAP150. As described earlier, BTM minigene consists of 4 exons and 3 introns
(Figure 24A). Exon 6 in this minigene cassette shows alternative splicing defects.
Previous studies from our laboratory have shown alternative splicing of exon 6 after
depletion of another nuclear speckle protein called Son. Depletion of Son caused
alternative skipping of exon 6 as compared to control cells (Figure24B, lanes 6-7;
Sharma et al., 2011). BTM HeLa cells were depleted of Btf or TRAP150 by siRNA
transfection (Figure 24D) and 72 hours post transfection total RNA was extracted. RTPCR analysis using exon 5-6-7 primers showed that there was no altered splicing upon
Btf or TRAP150 depletion as compared to the control cells. All the unspliced, spliced
and exon 6 skipped transcript levels were the same as inthe control (Figure 24B, lanes
2-5). However, there was an increase in the total BTM transcript level seen in Btf and
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Figure 24. Depletion of Btf or TRAP150 does not alter splicing on BTM transcripts
but increases abundance oftotal BTMtranscripts in the cell.
A. Schematic representation of the rat beta-tropomyosin locus. A1 and A2 are the
primers used against the region exon5-6-7 as shown.
B. Btf or TRAP150 depletion does not cause splicing defects. BTM HeLa cells were
transfected with 60 pmoles ofa control siRNA (C), Btf siRNA1 (B1), Btf siRNA2 (B2),
TRAP150 siRNA1 (T1) or TRAP150 siRNA4 (T4). 72 hours post-transfection, total RNA
was extracted as per the protocol. RT-PCR products from reactions using primer set A
(exon 5 to exon 7) were analyzed using native polyacrylamide gel electrophoresis to
examine alternative spliced products; corresponding products are diagrammed on the
right. –RT indicates reactions in which reverse transcriptase was omitted. Son siRNA4
was used as a positive control that shows exon 6 skipping (Sharma et al., 2011).
C. Fold change analysis of the transcripts showed a 2-fold increase in the BTM
transcripts in Btf-depleted (BtfSi1, BtfSi2) and TRAP150 (TRAPSi1, TRAPSi4).
D. Immunoblot confirming the depletion of Btf and TRAP150. Btf (B1, B2) and TRAP150
(T1, T4) expression was significantly reduced compared to control (C). Beta-actin was
used as a loading control. Son siRNA samples were used from earlier studies (Sharma
et al., 2011).

105	
  
	
  
	
  

	
  
	
  

106	
  
	
  
	
  

	
  
	
  

TRAP-depleted samples (Figure 24C). Thus, this suggested that both these proteins
might not have any role in splicing regulation on BTM reporter transcripts. It is possible
that altered splicing may occur on other minigene reporters (Heyd et al., 2010, Lee et
al., 2010, Sarras et al., 2010), or on endogenous pre-mRNAs. Since altered splicing
was not observed on BTM transcripts in Btf- and TRAP150-depleted cells, we next
examined subcellular distribution of polyadenylated RNA.
Btf and not TRAP150 affect the mRNA distribution in cytoplasm.
A complex of proteins that comprises the exon junction complex, or EJC carries
out export of mRNA into the cytoplasm. This complex of proteins is deposited on
mRNAs as a consequence of pre-mRNA splicing and occurs at 20-25 nt upstream of
the site of each intron excision. Since earlier we observed colocalization of Btf and
TRAP150 with the exon junction complex protein Magoh at active transcription sites in
U2OS 2-6-3 reporter cells, and since Btf/TRAP150 and EJC proteins have been
identified in the same complex (Custodio et al., 2004; Lee et al., 2010), we next
examined if silencing Btf or TRAP150 expression affects the cellular distribution of the
BTM reporter transcripts. Two different siRNA oligos targeting Btf (BTFSi1; B1 and
BtfSi2; B2) or TRAP150 (TRAPSi1; T1 and TRAPSi4; T4) were used for depletion in
BTM HeLa cells and total, nuclear and cytoplasmic RNA was extracted. A duplicate set
of samples used for protein extraction showed significant reduction in Btf (B1, B2) and
TRAP150 (T1, T4) as compared to controls (Figure 25B). These nuclear and
cytoplasmic fractions were verified by qRT-PCR analysis of specific nuclear (U2snRNA)
and cytoplasmic (S14) RNA markers for 18 cycles and then showing the enrichment of
U2snRNA in nuclear fractions and S14 in cytoplasmic fraction (Figure 22C) by native
PAGE. qRT-PCR using exon 5 primers targeting BTM transcripts revealed that Btf
depletion caused more than two-fold increase in cytoplasmic BTM, while there was no
increase in cytoplasmic BTM in TRAP-depleted cells (Figure 25A; grey bars). On the
other hand, TRAP150-depleted samples showed a moderate increase in nuclear BTM
transcripts consistent with a previous study (Lee et al., 2011).
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Figure 25. Depletion of Btf and not TRAP150 increases levels of BTM transcripts
in the cytoplasm.
A. A representative graph of three qRT-PCR experimental replicates using exon 5
(forward and reverse) primers is shown for one representative of three independent
experiments having similar outcomes, showing the relative change in the BTM
transcripts when normalized to GAPDH. Equal amounts of nuclear and cytoplasmic
RNA (100ng/µl) were used for qRT-PCR. Black bars represent nuclear BTM RNA while
grey bars represent cytoplasmic BTM RNA.
B. Immunoblots from cells treated in parallel confirm depletion of Btf or TRAP150. Betaactin was used as a loading control.
C. Validation of nuclear/cytoplasmic RNA fractionation by qRT-PCR using primers
targeting human U2 snRNA (nuclear) and S14 (cytoplasmic) on total (lane T), nuclear
(lane N) and cytoplasmic (lane C) RNA samples.
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(Figure 25A; black bars). Thus, this suggested that Btf has a role in regulating the
cellular distribution of BTM transcripts that is not shared by TRAP150.
Btf depletion does not alter recruitment of RNA processing factors to
transcription sites.
Decreasing expression of one protein may in turn alter the assembly or targeting
of its interacting partners. Reducing the amount of Btf at transcription sites could affect
targeting of other mRNA processing factors to transcription sites, leading to indirect
effects on mRNA distribution. Since Btf depletion caused a significant increase in
cytoplasmic BTM transcripts, we next examined if Btf depletion affected targeting of
other RNA processing factors to this reporter locus. Changes in recruitment of other
mRNA processing factorsto the BTM locus were determined following Btf depletion by
RNA-FISH after 72 hours of siRNA transfection. The cells treated with two different
siRNA oligos targeting against Btf showed significant reduction in Btf as seen by SDSPAGE (Figure 26B, 27B, 28B). Btf-depleted cells using two different siRNA duplexes
showed recruitment of SRSF1 (Figure 26 k-t) did not change as compared to cells
treated with control siRNA duplexes (Figure 26 a-j). Similarly, Btf-depleted cellsshowed
recruitment of YFP-TRAP150 (Figure 27 k-t) to the BTM transcription site at levels
comparable to what was observed in cells treated with control siRNA duplexes
(Figure27 a-j). Also, Btf-depleted cells using two different siRNA duplexes showed
recruitment of YFP-Magoh (Figure 28 a-j) to the same extent as in cells treated with
control siRNA duplexes (Figure 28 k-t). Therefore, it is most likely that the changes seen
in cellular mRNA distribution are a direct effect of Btf depletion rather than altered
recruitment of partner proteins.
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Figure 26. Depletion of Btf does not prevent recruitment of SF2/ASF to the BTM
transcription site.
A. BTM HeLa cells were transiently transfected with YFP-Magoh. 24 hours posttransfection, the cells were again transfected with 60 pmoles of either control siRNA
(panels a, k and u) or Btf siRNA 1 (panels f, p and z). 72 hours post-transfection, the
cells were processed for RNA-FISH localization of reporter RNA using oligos against
exon 5 (panels b, g, l, q) as described (Sharma et al., 2011) and immunofluorescence
localization of Btf or SRSF1. Arrows indicate the BTM transcription site. DNA was
stained with DAPI. Scale Bar, 5 µm.
B. Immunoblot confirming depletion of Btf or TRAP150. Actin was used as a loading
control.
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Figure 27. Depletion of Btf does not prevent recruitment of TRAP150 to the BTM
transcription sites.
A. BTM HeLa cells were transiently transfected with YFP-TRAP150. 24 hours posttransfection, the cells were again transfected with 60 pmoles of either control siRNA
(panels a, k and u) or Btf siRNA 1 (panels f, p and z). 72 hours post-transfection, the
cells were processed for RNA-FISH localization of reporter RNA using oligos against
exon 5 (panels b, g, l, q) as described (Sharma et al., 2011) and immunofluorescence
localization of Btf or GFP. Arrows indicate the BTM transcription site. DNA was stained
with DAPI. Scale Bar, 5 µm.
B. Immunoblot confirming depletion of Btf. Actin was used as a loading control.
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Figure 28. Depletion of Btf does not prevent recruitment of Magoh to the BTM
transcription sites.
A. BTM HeLa cells were transiently transfected with YFP-Magoh. 24 hours posttransfection, the cells were again transfected with 60 pmoles of either control siRNA
(panels a, k and u) or Btf siRNA 1 (panels f, p and z). 72 hours post-transfection, the
cells were processed for RNA-FISH localization of reporter RNA using oligos against
exon 5 (panels b, g, l, q) as described (Sharma et al., 2011) and immunofluorescence
localization of Btf or GFP. Arrows indicate the BTM transcription site. DNA was stained
with DAPI. Scale Bar, 5 µm.
B. Immunoblot confirming depletion of Btf. Actin was used as a loading control.
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Btf depletion causes an increase in the global cytoplasmic pool of polyadenylated
RNA.
To test the effect of Btf depletion on global nuclear/cytoplasmic distribution
ofmRNAs, I performed RNA-FISH using oligo-dT probes to examinepolyadenylated
RNA in Btf- or TRAP150-depleted HeLa cells (Figure29). Immunoblots showed that
there was significantly reduced expression of Btf (Figure 29C; compare lane 1 to lanes
2-3) and TRAP150 (Figure 29D; compare lane 1 to lanes 4-5) by their respective siRNA
oligos as compared to control. RNA-FISH showed that depletion of Btf with two different
siRNA duplexes increased the abundance of cytoplasmic polyadenylated RNA (Figure
29A f, j) as compared to controls (Figure 29A b). Although, no change in the distribution
of polyadenylated RNA was seen in cells depleted of TRAP150 (Figure 29B). This
suggested that the change in poly (A)+ RNA distribution is mainly due to Btf depletion.
Immunoblots indicated that TRAP150 protein levels were upregulated in Btf-depleted
cells, while Btf protein levels were upregulated in TRAP150-depleted cells (Figure 29C
and 29D), suggesting that the two proteins may functionally compensate for one
another. It also left the question as to whether it is the absence of Btf or the increase in
TRAP150 that is responsible for the cytoplasmic increase in polyadenylated RNA. We
found that compensatory TRAP150 expression in Btf-depleted cells could be prevented
by addition of limiting amounts of TRAP150 siRNA duplex along with the Btf siRNA
duplex (Figure 31B compare lanes 2 and 7 and Figure 30C). By adding limiting amounts
of TRAP150 siRNA duplex to the siRNA mixture, the level of TRAP150 expression was
maintained at levels approximately equal to that of controls (Figure 31B, compare lanes
1 and 6) whereas expression of Btf was reduced (Figure 31B, compare lanes 1 and 6)
in the same sample. When TRAP150 upregulation was prevented during Btf depletion,
an increase in cytoplasmic polyadenylated RNA was observed as compared to controls
(Figure 31A, compare b and f). The ratio of nuclear/cytoplasmic pixel intensity for
polyadenylated RNA signal for 50 cells was calculated in samples treated with nontargeting siRNA (control), siRNA targeting Btf (B1, B2) and TRAP150 (T1, T4). Btfdepleted cells (Figure 31D; 0.69 in B1, 0.75 in B2) showed less nuclear/cytoplasmic
ratio than in cells treated with control siRNA duplexes (1.9; Figure 31D) whereas, the
ratio of nuclear/cytoplasmic pixel intensity for polyadenylated RNA signal in TRAP150117	
  
	
  
	
  

	
  
	
  

depleted cells (Figure 31D; 2.0 in T1, 1.79 in T2) compared to controls (Figure31D; 1.9)
showed no change. Thus, we observed that Btf depletion and not compensatory
TRAP150 upregulation leads to the change in subcellular distribution of polyadenylated
RNA. Further studies needs to be done to identify any endogenous gene targets of Btf
and/or TRAP150 depletion. In an attempt to study the change in localization of two
known nuclear RNA such as U2snRNA and the long non-coding RNA MALAT1, we
knockdown Btf or TRAP150 using two different siRNA duplexes against Btf or TRAP150
along with control siRNA. The cells were processed 72 hrs post transfection for RNAFISH using fluorescently tagged oligos for MALAT1 and U2snRNA (Figure 32).
Compared to cells treated with control siRNA (Figure 32A or B a-e), the cells depleted
of Btf (Figure 32A f-o) or TRAP150 (Figure 32B f-o) showed no change in localization
pattern of either MALAT1 or U2snRNA.
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Figure 29. Cytoplasmic polyadenylated RNA increases following depletion of Btf
but not TRAP150.
A and B. HeLa cells were transfected with control siRNA, siRNA oligos specific for Btf
(BtfSi1 and BtfSi2) or siRNA oligos specific for TRAP150 (TRAPSi1 and TRAPSi4).
Cells were processed 72 hours post-transfection for RNA-FISH using Texas Redconjugated

oligo-dT50

to

visualize

polyadenylated

RNA,

followed

by

immunofluorescence with antibodies against Btf (WU10) and TRAP150 (Bethyl).
C. Immunoblots showing relative expression levels of Btf or TRAP150. Beta-actin was
used as a loading control. Data set shown is a representative of three independent
experiments having similar results. Btf and TRAP150 band intensities in immunoblot
were quantified using Fujifilm Image Gauge 4.0 and normalized to the corresponding
beta-actin band intensity. Results are expressed as fold change (%) in Btf or TRAP150
siRNA-treated compared to the control. Error bar represents s.d. in two replicate
immunoblots. Scale bar, 5 µm.
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Figure 30. Upregulation of TRAP150 following Btf depletion can be prevented by
adding limiting amounts of TRAP150 siRNA oligos.
Immunoblots and corresponding densitometry plots showing relative expression levels
of Btf or TRAP150. Beta-actin was used as a loading control. HeLa cells were depleted
of Btf (BtfSi1) as shown in A and serial dilution of TRAPsiRNA oligo (TRAPSi4; 10-, 20-,
40-, 50- and 70-fold dilutions) as shown in B. Their corresponding densitometry plots
showing relative fold change in TRAP150 protein expression as shown in C.
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Figure 31. Cytoplasmic polyadenylated RNA increases in Btf-depleted cells when
compensatory upregulation of TRAP150 is blocked.
A. HeLa cells were transfected with control siRNA or a mixture of BtfSi1 and
TRAP150Si4. 72 hours post transfection, the cells were processed for RNA-FISH using
Texas Red-conjugated oligo-dT50 to visualize polyadenylated RNA distribution.
B, C. Immunoblots and corresponding densitometry plots showing relative expression
levels of Btf or TRAP150. Beta-actin was used as a loading control.
D. Graph of nuclear versus cytoplasmic ratio of polyadenylated RNA. Total fluorescence
measurements were performed using ImageJ software. Each bar represents an
average of pixel intensities for nuclear poly (A)+ RNA divided by the average pixel
intensities for cytoplasmic poly (A)+ RNA in 25 cells. Error bars represent s.d. of
fluorescence intensities. Scale bar, 5 µm.
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Figure 32. Depletion of Btf or TRAP150 does not change the distribution of
MALAT1 lncRNA or U2snRNA.
HeLa cells were transfected with control siRNA, and siRNA oligos specific for (A) Btf
(BtfSi1; B1 and BtfSi2; B2) or (B) TRAP150 (TRAPSi1 and TRAPSi4). Cells were
processed 72 hours post-transfection for RNA-FISH using Texas Red-conjugated
MALAT1 probeto visualize MALAT1 lncRNA and Cy5 conjugated U2snRNA oligo porbe
followed by immunofluorescence labelling of Btf using WU10 antibody. Scale bar, 5 µm.
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CHAPTER 4
Btf and TRAP150 are important for proper cell cycle progression.
Depletion of Btf or TRAP150 causes chromosome misalignmentat metaphase.
In order to determine if Btf has mitotic functions, HeLa cells were treated with
control siRNA oligos or siRNA duplexes against Btf. 72 hourspost-transfection, Btf
depletion was confirmed by immunofluorescence (Figure 33A) and SDS-PAGE (Figure
33B). DNA staining with DAPI revealed that depletion of Btf by two different sets of
siRNA duplexes against Btf in HeLa cells caused misalignment of chromosomes at
metaphase (Figure 33A k-t). There was a 10% increase in the number of mitotic cells in
Btf-depleted cells observed following knockdown of Btf with two different siRNA
duplexes (Figure 35A). Chromosome alignment was scored in 100 metaphase cells for
each condition. There was a 40% increase in metaphase defects in Btf-depleted cellsas
compared to control cells (Figure 35B). Similar results were observed after depletion of
TRAP150 in HeLa cells (Figure 34) (Torres-Munoz, 2012). Interestingly, depletion of
TRAP150 also showed chromosome separation defects in telophase (possibly due to
incomplete cleavage of cohesion complexes between sister chromatids) that was not
seen following Btf depletion (Figure 34). 72 hours post-transfection of siRNA duplexes,
the cells depleted of TRAP150 showed defects such as micronuclei and chromosomal
bridges in telophase as compared to control siRNA transfected cells (Figure 34). Flow
cytometry analysis of unsynchronized HeLa cells revealed that Btf depletion (BtfSi1 or
BtfSi2) or TRAP150 (TRAPSi1 or TRAPSi4) depletion caused a 10-12% increase in the
number of cells in G2/M phase, while there was no significant change in the cell cycle
profile of control cells (Figure 36A). Immunoblot of extracts from samples treated in
parallel showed significant reduction in Btf and TRAP150 expression as compared to
control cells (Figure 36C). Actin was used as a loading control (Figure 36C, bottom
panel). This data indicates that Btf and TRAP150 are necessary for normal cell cycle
progression in HeLa cells.
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Figure 33. Depletion of Btf causes misalignment of chromosomes at metaphase.
A. HeLa cells grown on coverslip were transfected with Mock siRNA (vehicle) (a-e),
control siRNA targeting luciferase (60 pmoles) (f-j), Btf siGenome1 (60 pmoles) (k-o)
and Btf siGenome2 (p-t). 72 hours post transfection the cells were processed for
immunolabelling against ACA (1:3000), Tubulin (1:3000) and Btf (1:2500). DNA was
stained with DAPI. Scale bar, 5 µm.
B.Cells treated in duplicate wereextracted for SDS-PAGE and immunoblotting to
confirm depletion of Btf. Actin was used as a loading control.
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Figure 34. Depletion of TRAP150 causes chromosomal defects at telophase.
A. HeLa cells grown on coverslip were transfected with control siRNA targeting
luciferase (60 pmoles) (a-e), TRAP siGenome1 (60 pmoles) (f-j). 72 hours post
transfection the cells were processed for immunolabelling against ACA (1:3000),
Tubulin (1:3000) and TRAP150 (1:1000). DNA was stained with DAPI. Scale bar, 5 µm.
B. Cells treated in duplicate were processed for immunoblotting against Btf to confirm
depletion. Actin was used as a loading control.
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Figure 35. Depletion of Btf causes an increase in mitotic index.
A. Mitotic index was scored forHeLa cells treated with two different siRNA duplexes
(BtfSi1, BtfSi2) or control siRNA duplexes. Blue bars represent normal mitotic cells
whereas red bars represent mitotic cells with chromosomal defects. 500 cells were
scored per sample.
B. From the same experiment, 100 metaphase cells were scored for misalignment
defects.
C. From a separate experiment, 1000 mitotic cells in each condition (BtfSi1, BtfSi2,
control siRNA, mock) were scored for mitotic defects at different phases of mitosis.
N represents normal cells, D represents defects.
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Mitotic checkpoint proteins localized to misaligned chromosomes at metaphase
in Btf-depleted cells.
Next, I tested whether the spindle checkpoint proteins are recruited to the misaligned
chromosomes. To address this, the localization of mitotic checkpoint proteins such as
CENP-E (a microtubule dependent motor protein), CENP-F or Aurora B (a mitotic
checkpoint protein that oversees proper kinetochore-microtubule attachments) was
analyzed at kinetochores of the misaligned chromosomes following Btf depletion. If the
checkpoint is active, these mitotic checkpoint proteins should localize to the
kinetochores of misaligned chromosomes. Triplicate sets of HeLa cells were depleted of
Btf using siRNA duplexes against Btf (BtfSi1 or BtfSi2) or control siRNA duplexes. 72
hours post-transfection, the cells were immunolabeled for Btf, ACA and BubR1/CENPE/Aurora B (Figures 37-39). DNA staining by DAPI revealed misaligned chromosomes,
and immunolabeling showed that the mitotic checkpoint proteins CENP-E (Figure 37),
CENP-F (Figure 38) and Aurora B (Figure 39 k-t) localized to the kinetochores of the
misaligned chromosomes in Btf-depleted cells. Interestingly, immunofluorescence
showed that Aurora B localized with higher intensities at the misaligned chromosomes
as compared to the aligned chromosomes at metaphase in Btf-depleted cells (Figure 39
l-o and q-t). This was consistent with our immunoblot data and histogram of band
densitometry that showed increased protein expression of Aurora B in Btf-depleted cells
as compared to control (Figure 40B, compare lanes 2c and 3c with 1c in A to
densitometry graphs in B). Btf depletion in BtfSi1 and BtfSi2 samples was confirmed by
immunoblotting against Btf (Figure 40A lanes 2a and 3a compared to 1a). Actin was
used as a loading control (Figure 40A, lanes 1b-3b). Similar results were observed upon
TRAP150 depletion (Torres-Munoz, 2012). Thus these localization studies indicated
that the checkpoint proteins are able to recognize and localize to the misaligned
chromosomes in Btf- or TRAP150-depleted cells.
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Figure 36. Depletion of Btf and TRAP150 in HeLa cells shows an increase in G2/M
phase cells.
A. Flow cytometry analysis of HeLa cells 72 hrs post transfection with control siRNA,
siRNA against Btf (BtfSi1, BtfSi2) and siRNA against TRAP150 (TRAPSi1, TRAPSi4).
B. Graphical representation of the distribution of cells (%) in cell cycle based on the flow
cytometry data.
C. Immunoblot confirming the depletion of Btf and TRAP150 in the samples.
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Figure 37. Localization of CENP-E to misaligned chromosomes at metaphase in
Btf-depleted cells.
A. HeLa cells were transfected with siRNA against control luciferase and Btf (using two
siRNA duplexes; BtfSi1, BtfSi2). 72 hrs post transfection, the cells were processed for
immunolocalization of Btf (a, g, m), CENP-E (b, h, n) and ACA (c, i, o). DNA was
stained with DAPI. Arrows indicate misaligned chromosomes.
B. Immunoblot confirming depletion of Btf. Actin was used a loading control.
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Figure 38. CENP-F localizes to misaligned chromosomes at metaphase in Btfdepleted cells.
A. HeLa cells were transfected with siRNA duplexes against luciferase (control) or Btf
using BtfSi1. 72 hrs post-transfection the cells were processed for immunolocalization of
Btf (monoclonal antisera), CENP-Fand ACA. DNA was stained with DAPI. Arrows
indicate misaligned chromosomes.
B. Immunoblot confirming depletion of Btf. Actin was used a loading control.
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Figure 39. Aurora B localizesto misaligned chromosomes at metaphase in Btfdepleted cells.
A. HeLa cells were transfected with mock (siRNA buffer), siRNA against control
luciferase and Btf (using two siRNA duplexes; BtfSi1, BtfSi2). 72 hrs post-transfection,
the cells were processed for immunolocalization of Btf (a, f, k, p), Aurora B (b, g, l, q)
and ACA (c, h, m, r). DNA was stained with DAPI.Arrows indicate metaphase plate in
mock and control panels ormisaligned chromosomes in BtfSi1 and BtfSi2 panels.
B. Immunoblot confirming depletion of Btf. β-Actin was used a loading control
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Figure 40. Upregulation of Aurora B protein expression in Btf-depleted cells.
A.HeLa cells were transfected with control siRNA and siRNA duplexes against Btf and
whole cell nuclear extracts were prepared 72 hrs post siRNA transfection. The samples
were run on SDS-PAGE and blotted against different antibodies against Btf (to confirm
depletion), Actin (as a loading control), Aurora B, Mad2, Cdc20 and BubR1. Aurora B
showed an increase in protein expression in Btf-depleted samples (lanes 2c and 3c as
compared to 1c).
B. Densitometry analysis on AURK-B protein expression as compared to the loading
control β-actin. This shows a 22-fold increase in AURK-B protein levels upon Btf
depletion by two different siRNAs (BtfSi1, BtfSi2) as compared to β-actin.
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Time-lapse microscopy revealed that reduction of Btf and TRAP150 in HeLa-H2BYFP cells resulted in delayed mitotic progression.
There are two possible explanations for the slight increase in the number of
G2/M phase cells observed after Btf or TRAP150 depletion. Perhaps mitotic delay was
difficult to detect in an asynchronous population of cells, or perhaps the cells continue to
divide after a short mitotic delay. Another unanswered question was what happens to
the misaligned chromosomes. Do they remain misaligned or do they align at later
stages of cell cycle? To analyze if mitotic progression occurred in the presence of
misaligned chromosomes, I performed time-lapse microscopy using HeLa cells stably
expressing histone H2B tagged with YFP (H2B-YFP).The chromatin in these cells can
be visualized directly, since H2B-YFP assembles into nucleosomes (Kanda et al.,
1998). HeLa H2B-YFP cells were plated on a 60mm coverslip and transfected with
siRNA duplexes against the control luciferase and Btf. 72 hrs post transfection the cells
were then seeded onto FCS2 chamber system (Bioptech, Butler, PA) for time lapse
microscopy. Mitotic cells were located and Z-stacks of images were acquired every 3
minutes (for control, BtfSi1, BtfSi2, TRAPSi1, TRAPSi4) for upto 2 hours till the cells
were in telophase. The cells transfected with control siRNA showed proper cell cycle
progression (Figure 41) and took 60 minutes to complete one cycle of mitosis from
prometaphase to telophase (Figure 41; prometaphase a-c, metaphase d-k, anaphase ln and telophase o-y). As expected, the cells transfected with Btf siRNA1 showed
misalignment of chromosomes at metaphase (Figure 42 a-x, arrow heads). A limited
population of cells imaged, with Btf depletion showing misaligned chromosomes at
metaphase, failed to progress to anaphase (Figure 42). The majority of misaligned
chromosomes seen at metaphase in Btf-depleted cells (Figure 43 white arrows) were
able to eventually align, but mitotic progressiontook longer (around 76 min) from
prometaphase to metaphase (Figure 43 f-x). However, more time-lapse movies needs
to be collected in order to understand the fate of the misaligned chromosomes at
metaphase in Btf-depleted cells. Similar results were observed upon TRAP150
depletion in asynchronous HeLa-H2B-YFP cells by time-lapse microscopy (Torres-
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Munoz, 2012). Hence our data indicates that both Btf and TRAP150 are important in
maintaining proper chromosome segregation as well as timing of mitotic events.
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Figure 41. Cell cycle progression in HeLa cells stably expressing H2B-YFP.
Time-lapse imaging of HeLa cells stably expressing H2B-YFP 72 hrs post siRNA
transfection with Control siGenome2. The cell was imaged from prometaphase to
telophase.
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Figure 42. Mitosis does not progress past metaphase after Btf depletion in HeLa
cells stably expressing H2B-YFP.
Time-lapse imaging of HeLa cells stably expressing H2B-YFP transfected with Btf
siGenome1. Live movies were initiated 72 hrs post siRNA transfection. The cell was
imaged from prometaphase and remained in metaphase.
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Figure 43. Time-lapse imaging of chromosome misalignment at metaphase after
Btf depletion in HeLa cells stably expressing H2B-YFP.
Time-lapse imaging of HeLa cells stably expressing H2B-YFP transfected with Btf
siGenome1. Live movies were initiated 72 hrs post siRNA transfection. Chromosomal
misalignment defects at metaphase are indicated witharrows. Another cell (arrow head)
also showed misalignment of chromosomes as it progressed fromprometaphase to
metaphase.
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Depletion of Btf and TRAP150 in HeLa-H2B-YFP cells resulted in mitotic arrest.
Depletionof Btf or TRAP150 both showed defects in cell cycle progression by
immunofluorescence, so next I wanted to study the effect of Btf or TRAP150 depletion
on the distribution of cell cycle. To address this, flow cytometry analysis was performed
on asynchronous HeLa cells following combined depletion of Btf (using BtfSi1; 60
pmoles) and TRAP150 (using TRAPSi4; 30 pmoles) after 72 hours of siRNA
transfection (these samples are refered as BT). The control siRNA transfected cells
showed a normal cell cycle distribution with 11% of cells in G2/M and 75% in
G1(Ormerod, 1992). Btf-depleted or TRAP150-depleted cells showed a 10% increase in
G2/M, consistent with our earlier results (Figure 36), whereas the cells depleted of Btf
(using two different siRNA duplexes) and TRAP150 (using TRAPSi4 siRNA oligos)
showed 37% of cells in G2/M and 36% in G1 phase of the cell cycle 72 hours after
siRNA transfection (Figure 44). In addition, there were an increased number of cells
having 4N DNA content, which implies that sister chromatids were not properly
segregated into daughter cells but rather remained within a single cell. Furthermore, a
ViCell count was performed to monitor cell growth showed that Btf depletion, TRAP150
depletion or combined Btf and TRAP150 depletion caused cells to grow at a slower rate
as compared to the mock and control siRNA treated cells (Figure 45). The cells
depleted of Btf and TRAP150 also showed more cell death after 48 hours of siRNA
transfection (Figure 45). Taken all together, this set of data suggests that Btf and
TRAP150 depletion interferes with cell growth and has detrimental effects on the cell
cycle distribution of HeLa cells. Furthermore, examination of cells following combined
Btf and TRAP150 depletion revealed that the mitotic cells showed more defects.
Misalignment of chromosomes was observed at metaphase plate, and there were
defects in chromosome congression (Figure 47). In addition, there were many
fragmented nuclei observed. Further, Btf and TRAP150 were depleted in asynchronous
HeLa-H2B-YFP cells by transfecting siRNA oligos targeted againstBtf (BtfSi1) and
TRAP150 (TRAPSi4) and analyzed by time-lapse microscopy to determine the fate of
the misaligned chromosomes. Images were taken every 30 minutes across the z-stack.
The cells depleted of Btf and Trap150 showed severe misaligned chromosomes at
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metaphase, which failed to align in later stages of the cell cycle and that cell either
showed defective cytokinesis (Figure 49 k-o) or mitotic arrest (Figure 48 a-dd).
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Figure 44.Double depletion of Btf and TRAP150 in HeLa cells causes mitotic
arrest.
HeLa cells were transfected with siRNA duplexes against Btf (BtfSi1; 60 pmoles) and
TRAP150 (TRAPSi4; 30 pmoles) or control siRNA (60 pmoles). 72 hours post
transfection the cells were harvested for flow cytometry analysis. Cell cycle analysis
showed 37% of cells in G2/M as compared to 11% cells in control. A simultaneous
decrease in G1 phase of the cell cycle and an increase in 4N cell populationwas
observed in Btf- and TRAP-depleted cells. A graphical representation of the same flow
cytometry data is also shown.
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Figure 45. Btf and TRAP150 affects cell viabiity and growth in HeLa cells.
HeLa cells were transfected with siRNA duplexes against Btf (BtfSi1; 60 pmoles),
TRAP150 (TRAPsi4) or Btf and TRAP150 (60 pmoles of BtfSi1 and 30 pmoles of
TRAPSi4) or control siRNA (60 pmoles) or mock (vehicle). The cells were harvested at
different time points (0 hr, 24 hr, 48 hr, 72 hr) post transfection, andcell viability was
analyzed by ViCell analyzer. Another set of samples treated simultaneously was
harvested for immunoblotting to confirm depletionof Btf and TRAP150. Actin was used
as loading control.
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Figure 46. Depletion of Btf and TRAP150 causes mitotic arrest.
A.HeLa cells were transfected with siRNA duplexes against Btf (BtfSi1; 60 pmoles) and
TRAP150 (TRAPSi4; 30 pmoles) or control siRNA duplex (60 pmoles). 72 hours post
transfection the cells were harvested for immunolocalization of Btf (1:2500; a, f, k),
Tubulin (1:3000; b, g, l) and ACA (1:3000; c, h, m). DNA was stained with DAPI (e, j, o).
Scale bar, 5 µm.
B.Immnoblot of HeLa samples 72 hours post-transfection of siRNA against control
siGenome2,

BtfSi1,

BtfSi2,

TRAPSi1,

TRAPSi4,

BT

(BtfSi1

and

TRAPSi4)

immunolabeled for β-actin (as loading control), polyclonal anti-TRAP150 (Bethyl) and
monoclonal phospho-H3 (marker for mitotic arrest).
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Figure 47. Time-lapse imaging showing chromosomal segregation defects in cells
depleted of Btf and TRAP150.
Time-lapse imaging of HeLa cells stably expressing H2B-YFP transfected with Btf
siGenome1 (60 pmoles) and TRAP150 siGenome4 (30 pmoles). Live imaging was
initiated 72 hrs post siRNA transfection. The cells were imaged from metaphase to
telophase.
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Figure 48. Time-lapse imaging showing mitotic defects in cells depleted of Btf
and TRAP150.
Time-lapse imaging of HeLa cells stably expressing H2B-YFP transfected with Btf
siGenome1 (60 pmoles) and TRAP150 siGenome4 (30 pmoles). Live imaging was
initiated 72 hrs post siRNA transfection.
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Figure 49. Time-lapse imaging showing missegregation defects in cells depleted
of Btf and TRAP150.
Time-lapse imaging of HeLa cells stably expressing H2B-YFP transfected with Btf
siGenome1 (60 pmoles) and TRAP150 siGenome4 (30 pmoles). Z-stacks were
acquired every 30 min. Live imaging was initiated 72 hrs post siRNA transfection.
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Btf and TRAP150 are essential formaintaining proper expression and alternative
splicing of cell cycle regulator transcripts.
In order to identify genes with differential gene expression or alternative splicing,
we performed exon array analysis on HeLa treated with Btf-depleted (BtfSi1 and BtfSi2)
or TRAP150-depleted (TRAPSi4)compared to HeLa cells treated with control luciferase
siRNA. Gene expression profiles in these samples were examined by using the
AltAnalyze software program. Btf or TRAP150 depletion was confirmed in six replicate
sets of siRNA treated samples by immunoblot (Figure 50). Immunoblot analysis
revealed that as compared to control, sets 1-4 showed significant depletion of Btf by
BtfSi1 or BtfSi2 (Figure 50 upper panels). Similarly, sets 1-4 showed significant
depletion of TRAP150 by TRAPSi1 or TRAPSi4 siRNA duplexes (Figure 50, lower
panels). Microarray was performed by Dr. Michael Markey in the WSU CGR. We
detected that 31511 genes showed changes in their expression levels upon Btf siRNA,
out of which 2224 genes showed significant upregulation or downregulation (p-value ≤
0.005). Similarly, upon TRAP150 depletion we 31511 genes differentially expressed, out
of which 1082 showed significant upregulation or downregulation (p-value ≤ 0.005).
1028 genes showed 1.5-fold or higher upregulation in their gene expression after Btf
siRNA as compared to controls, and 617 genes showed 1.5-fold or moredownregulation of their gene expression after Btf siRNA as compared to controls. Upon
TRAP150 depletion, 477 genes showed 1.5-fold or higher up-regulation in their gene
expression as compared to control and 302 genes showed 1.5-fold or more downregulation of their gene expression after Btf siRNA as compared to control.
Exon Array results analyzed by Ingenuity iReport software programs showed that
Btf depletion caused a change in transcript abundance for genes in cell cycle, mitosis,
cell division, DNA replication, meiotic spindle organization, DNA repair, DNA replication
initiation, cyclin catabolic processes, endothelial cell morphogenesis, G2 phase of
mitotic cell division and many other pathways (Figure 51-52). Interestingly, the most
significant pathway affected in both Btf- or TRAP150-depleted samples was ‘cell cycle’.
The major mitotic checkpoint protein transcripts affected after Btf or TRAP150 depletion
by two different software programs are shown in Table 10 (Appendix A). The top 20
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most significant differentially expressed gene transcripts suggested by Altanalyze
showing up-regulation after Btf depletion are listed in Table 1 (Appendix A), whereas the
top 20 differentially expressed gene hits showing the most significant down-regulation
are listed in Table 2 (Appendix A). Similarly, the top 20 differentially expressed gene
transcripts showing the most significant up-regulation after TRAP150 depletion are
listed in Table 3 (Appendix A), whereas the top 20 differentially expressed gene hits
showing most significant down-regulation are listed in Table 4 (Appendix A). Btf or
TRAP150 depletion also showed many genes with alternative splicing defects. About
330 genes (414 exons in list) were differentially expressed upon Btf depletion, while 193
genes (245 exons in list) differentially expressed. Out of which 40 genes showed
significant (p-vaue ≤ 0.05) upregulation of exon inclusion (1.5-fold or higher) upon Btf
depeltion, whereas 30 genes showed significant (p-value ≤ 0.05) down regulation of
exon inclusion (1.5-fold or higher) upon Btf depletion. Genes showing downregulation of
exon inclusion (Exon Skipping) upon Btf depletion (BtfSi1) and TRAP150 depletion
(TRAPSi4) in Exon Array are shown in Table 5 and Table 7 respectively (Appendix A).
Similarly, genes showing upregulation of exon inclusion upon Btf depletion (BtfSi1) and
TRAP150 depletion (TRAPSi4) in Exon Array are shown in Table 6 and Table 8
(Appendix A).
Results from our exon array by two different software programs, Alt-analyze and
Ingenuity iReport, revealed that mitotic checkpointprotein transcripts altered upon Btf
and TRAP150 depletion were up-regulated 2-fold or higher (Table 10). This was further
validated by qRT-PCR (Figure 53) from the same RNA samples using different primer
pairs of mitotic checkpoint genes as shown in Table 9. Validations by qRT-PCR showed
that Aurora-B mRNA is increased 2-fold after Btf or TRAP150 depletion as compared to
the control (Figure 53, light blue bars). This increased mRNA abundance is consistent
with the immunolocalization studies done that showed an increased level of Aurora-B at
misaligned chromosomes during metaphase of Btf-depleted cells (Figure 39). CENP-E
transcripts increased 2.5-fold in Btf-depleted samples by BtfSi1 consistent with
microarray results (Table 10) and 4.2 fold in BtfSi2 treated samples (Figure 53, red
bars), whereas the CENP-E transcripts in TRAP150-depleted samples was increased
2.8-fold in TRAPSi1 samples consistent with the microarray data (Table 10) and 5.5 fold
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in TRAPSi4 samples. CENP-F transcripts increased 4-fold in Btf-depleted samples
(BtfSi1, BtfSi2) consistent with microarray results (Table 10) (Figure 53, green bars),
whereas the CENP-F transcripts in TRAP150-depleted samples increased 2.5-fold in
TRAPSi1 samples and 3.8-fold in TRAPSi4 samples. NDC80 transcripts increased 2.2fold in Btf-depleted samples by BtfSi1 and 3-fold in BtfSi2 treated samples consistent
with microarray results (Table 10) (Figure 53, orange bars), whereas the NDC80
transcripts in TRAP150-depleted samples was increased 2.8-fold in TRAPSi1 samples
and 2.9-fold in TRAPSi4 samplesconsistent with the microarray data (Table 11). Bub1B
transcripts increased 3.9-fold in Btf-depleted samples by BtfSi1 and 3.2-fold in BtfSi2
treated samples consistent with microarray results (Table 10) (Figure 53, blue bars),
whereas the Bub1B transcripts in TRAP150-depleted samples was increased 2.9-fold in
TRAPSi1 samples consistent with the microarray data (Table 10) and 5.2-fold in
TRAPSi4 samples. BUB1 transcripts increased 3-fold in Btf-depleted samples by BtfSi1
consistent with microarray results (Table 10) and 2-fold in BtfSi2 treated samples
(Figure 53, purple bars), whereas the BUB1 transcripts in TRAP150-depleted samples
was increased 1.8-fold in TRAPSi1 samples and 3.2-fold in TRAPSi4 samplesconsistent
with the microarray data (Table 10). This validates that key mitotic checkpoint
transcripts identified in microarray data analysisare in fact affected by Btf or TRAP150
depletion. This suggests that the mitotic chromosomal defects that are observed upon
Btf and TRAP150 depletion might be a consequence of misregulation of mitotic
checkpoint gene transcripts by Btf and TRAP150. Interestingly, exon array showed
defects in alternative splicing of certain cell cycle regulators upon Btf or TRAP150
depletion (Table 6, 7, 8, 9). Validations of those genes in future might shed light on the
role of Btf and TRAP150 in regulation of mitotic progression. The specific mechanism
underlying defective mitotic progressionand chromosome alignment/segregation still
needs to be elucidated.
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Figure 50. Immunoblot analysis showing depletion of Btf or TRAP150 in samples
used for Exon array.
Whole cell nuclear extracts from six replicate sets of HeLa cells transfected with Control
siGenome2 targeting luciferase (control; 60 pmoles; C), Btf (60 pmoles; BtfSi1, BtfSi2)
or TRAP150 (60 pmoles; TRAPSi1, TRAPSi4) were applied to SDS-PAGE and
immunoblotted using antibodies against Btf or TRAP150. Actin was used as a loading
control. Sets 1-4 were used for further exon array analysis.
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Figure 51. Graphical representation of the most significant GoProcess groups
affected by Btf depletion in Exon array by Altanalyze program.
RNA was extracted from six replicate sets of HeLa cells transfected with siRNA against
control (60 pmoles; C), Btf (60 pmoles; BtfSi1, BtfSi2) or TRAP150 (60 pmoles;
TRAPSi1, TRAPSi4) and used for exon array analysis. The most significant GoProcess
pathways affected were cell cycle and mitosis.
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Figure 52. Graphical representation of the differential gene expression forthe
most significantly affected pathway groups in Btf depletedcells.
RNA was extracted from six replicate sets of HeLa cells transfected with siRNA against
control (60 pmoles; C), Btf (60 pmoles; BtfSi1, BtfSi2) or TRAP150 (60 pmoles;
TRAPSi1, TRAPSi4) and used for exon array analysis. The most significant pathways
affected included cell cycle, DNA replication and G1-S transition.
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Figure 53. Validation of upregulation for major checkpoint protein transcripts
upon Btf or TRAP150 depletion.
RNA samples from control (60 pmoles; C), Btf (60 pmoles; BtfSi1, BtfSi2) or TRAP150
(60 pmoles; TRAPSi1, TRAPSi4) depleted cells were used for qRT-PCR analysis to
validate alterations in transcripts that encode mitotic checkpoint proteins.
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CHAPTER 5
DISCUSSION
Btf and TRAP150 localize to active transcription sites.
Nuclear speckles are sites for storage/assembly or modification of factors
involved in transcription and mRNA processing (Caceres et al., 1997; Huang and
Spector, 1991; Misteli et al., 1998; Misteli et al., 1997; Saitoh et al., 2004; Sutherland et
al., 2001). The pre-mRNA processing factors from these storage sites are then recruited
to transcription sites (Lamond and Spector, 2003). It is believed that the regulation of
splicing and transcription factors' activity is dependent on their ability to shuttle between
the nuclear speckles and sites of active transcription (Caceres et al., 1997; Misteli et al.,
1997; Saitoh et al., 2004; Sutherland et al., 2001). Btf and TRAP150 are two
uncharacterized nuclear speckle components (Mintz et al., 1999; Saitoh et al., 2004),
and knowing their functions will contribute to a better overall understanding about the
regulation of protein coding gene transcripts. While Btf has been previously linked to
apoptosis (Kasof et al., 1999), transcription (Ito et al., 2002; Ito et al., 1999; Kasof et al.,
1999; Liu et al., 2007) and Emery-Dreifuss Muscular Dystrophy (Haraguchi et al., 2004),
the precise mechanisms underlying cellular functions for Btf are still unknown.In
contrast, TRAP150 was initially identified as a subunit of the transcriptional regulatory
complex TRAP/mediator complex (Ito et al., 2002), although its association with that
complex has not been subsequently confirmed. Both Btf and TRAP150 have been
identified in spliceosomes and as part of different complexes having roles in RNA
processing or mRNA export (Bracken et al., 2008; Lee et al., 2010; Merz et al., 2007;
Wahl et al., 2009). Interestingly, both Btf and TRAP150 share a high degree of similarity
and identity in their primary amino acid sequence (Haraguchi et al., 2004; Lee et al.,
2010; Torres-Munoz, 2012), but their exact role in these mRNA processes is unclear.
The major aim of my thesis was to determine the cellular functions of Btf and TRAP150
and to elucidate if they have similar or distinct roles in mRNA processing.
Immunolocalization studies revealed that both Btf and TRAP150 demonstrated a
unique localization distribution in nucleoplasmic foci with some overlay with nuclear
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speckles (Figure 2) (Saitoh et al., 2004) unlike other SR proteins that are enriched at
nuclear speckles. Inhibition of RNAPII by amanitin completely redistributed Btf and
TRAP150 to colocalize with U1-70K at nuclear speckles (Figure 3). This suggested a
role of Btf and TRAP150 in mRNA processing, consistent with data reported by other
research groups that identified them in in-vitro affinity purified mRNPs and splicing
complexes (Merz et al., 2007; Wahl et al., 2009).
Btf and TRAP150 colocalize with the splicing factor SRSF1 and EJC component
Magoh at active transcription sites.
In an effort to understand the function of Btf in pre-mRNA processing, I
performed co-localization studies utilizing two different reporter gene loci. My data
showed accumulation of Btf and TRAP150 at both the BTM and the U2OS 2-6-3
reporter transcription sites (Figure 4 and Figure 10). Interestingly, their localization to
transcription sites diminished upon RNAPII inhibition, demonstrating that Btf and
TRAP150 localization to transcription sites is dependent on RNAPII activity (Figure 11).
Previous studies identified EJC components as interacting partners of Btf and TRAP150
and demonstrated a role of TRAP150 in splicing and nuclear mRNA decay (Lee et al.,
2010). To study the interaction of splicing factor SRSF1 or EJC component Magoh with
Btf or TRAP150 at transcription sites, we performed co-localization studies in U2OS 26-3 cells. I demonstrated that Btf and TRAP150 co-localized extensively (showed high
Pearson correlation coefficients) with SRSF1 and EJC component Magoh at reporter
transcription sites (Figure 17-20), consistent with previous reports that showed
recruitment of EJC components to active sites of transcription (Custodio et al., 2004).
Similar to previous studies, my immunoprecipitation results also demonstrated that Btf,
TRAP150 and Magoh are part of the same complex (Figure 22; Lee et al., 2010).
Previous reports suggest that this complex formation is independent of RNA interaction
(Lee et al., 2010).
Similarly, colocalization of Btf and TRAP150 with Magoh was observed at the
constitutively active BTM reporter locus that suggests that the interaction between these
proteins may be important in many cell types (Figure 21). Furthermore, we
demonstrated here that proteins having distinct functions in mRNA synthesis and
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processing localize to spatially distinguishable regions of the U2OS 2-6-3 reporter array.
Previous reports suggests co-recruitment of Btf and TRAP150 along with other SNARP
complex components to cyclin D1 gene downstream of the promoter region, as well as
TRAP150 and SNIP1 interaction with the 3'-UTR of cyclin D1 mRNA (Bracken et al.,
2008). These findings lend additional support to co-transcriptional interactions between
Btf/TRAP150 and other mRNA processing factors such as splicing factors and EJC
components. The U2OS 2-6-3 gene reporter array (Janicki et al., 2004) can therefore be
used to reveal potential partners and/or for assisting in functional categorization of many
other newly identified proteins having suspected roles in pre-mRNA synthesis and
processing.
Btf and TRAP150 may participate in splicing.
Association of Btf with in-vitro spliced mRNPs was independent of splicing but
mediated by cap binding complex (CBC) and was heparin-resistant, indicating that this
associationwas stable; in contrast, TRAP150 association with mRNPs was heparininsensitive and not CBC-dependent (Mertz et al., 2007). This suggests a distinct role of
Btf and TRAP150 in co-transcriptional splicing events. Our co-localization studies
demonstrating that Btf and/or TRAP150 show the most extensive overlap with SRSF1
and Magoh at the U2OS 2-6-3 reporter locus suggests all these proteins might share
similar roles in gene expression. SRSF1 (SF2/ASF) has been previously reported as an
important alternative and constitutive splicing factor. Previous studies demonstrated that
TRAP150 and Btf activated splicing in cells but not in a cell-free system, although the
role of Btf in splicing was not clear due to lack of ability to overexpress Btf(Lee et al.,
2010). Also, TRAP150 promoted splicing in vivo, activated mRNA degradation and coprecipitated with splicing factors and EJC proteins such as MLN51, RNPS1, REF,
Upf3b, Srm160 and Y14 (Lee et al., 2010). Yeast two-hybrid screening identified 9G8, a
well-established splicing regulator, as a direct interacting partner of Btf (Sarras et al.,
2010). However, we did not observe any alternative splicing defects for BTM reporter
transcripts upon Btf or TRAP150 depletion (Figure 24). While Btf or TRAP150 might not
have any roles in regulating splicing at BTM reporter locus, they may influence
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alternative splicing of specific endogenous gene transcripts as demonstrated from our
exon array data (Tables 5-8).
As a component of spliceosome, TRAP150 is loaded onto the RNA in complex
Bduring splicing, whereas Btf is a component of spliceosomal complex C that is loaded
on the RNA along with the EJC proteins (Wahl et al., 2009). This suggests that Btf and
TRAP150might have distinct roles in mRNA metabolism. Additionally, the studies done
earlier on Btf and TRAP150 have failed to distinguish the roles of Btf or TRAP150 in
splicing. Further experiments needs to be done to validate the endogenous gene targets
showing either exon skipping or exon inclusion upon Btf or TRAP150 depletion.
Investigating Btf dependent mRNA transcripts will provide new insights into novel
physiological pathways that might be regulated by Btf or TRAP150. Another approach
for investigating the role of Btf in splicing would involve use of in-vitro splicing assays
using E1A minigene that can be alternatively spliced. This can be achieved by
immunodepletion of Btf or TRAP150 from protein extracts to determine if splicing of
precursor transcripts is altered. If Btf or TRAP150 immunodepletion alters splicing, then
complementing the extracts with recombinant Btf or TRAP150 would rescue the splicing
defects. Moreover, the fact that Btf and TRAP150 have compensatory roles, it is
possible that depletion of one protein might be compensated by the upregulation of the
other.Thus, to overcome this one might have to deplete both in order to see any
significant defect in splicing in-vivo or in-vitro.
Btf and TRAP150 regulate subcellular distribution of mRNA.
Our approach for investigating the putative role of Btf and TRAP150 in mRNA
export involved looking at the change in BTM reporter transcripts in the nucleus and
cytoplasm of Btf- or TRAP150-depleted cells. We observed an increase in BTM
transcripts in the cytoplasmic RNA fraction upon Btf depletion (Figure 25) that suggests
its role in nuclear mRNA retention, possibly by regulating the ability of the EJC
components to export the properly spliced mRNA. One possibility is that Btf might be
important in checking the proper processing of mRNA prior to its export into the
cytoplasm. Interestingly, TRAP150 depleted cells did not show any cytoplasmic
increase in BTM transcripts but instead had a moderate increase in nuclear transcripts
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consistent with a previous report showing its role in nuclear mRNA decay (Lee et al.,
2010). Since degradation of TRAP150-tethered mRNA occurred in the nucleus,
irrespective of translational activity suggested that it may have an indirect role in nuclear
mRNA decay, which is distinct to canonical NMD (nonsense mediated decay). Most
importantly, experiments to test the global effects on mRNA demonstrated that
depletion of Btf, but not TRAP150, caused accumulation of polyadenylated RNA in the
cytoplasm of HeLa cells (Figure 29). We therefore provide the first evidence showing
distinct functions of Btf and TRAP150 in regulating the cellular distribution of mRNA.
The mechanism for this difference still remains to be discovered. TRAP150 induced
mRNA decay was not similar to canonical NMD, as it did not occur in cytoplasm and
was not affected by translation factor Upf (Lee et al., 2010).In support of this previously
known function for TRAP150, our dataalso provides evidence that TRAP150 promotes
nuclear mRNA export (Lee et al., 2010). Interestingly, this function is not shared with its
homolgue Btf, which was observed to promotenuclear mRNA retention in our data.
Alternatively, Btf might regulate the RNA stability of certain pool of transcripts consistent
with earlier reports showing regulation of cyclin D1 mRNA stability by Btf (Bracken et al.,
2008). NXF1/TAP interacts with other RNA-binding adaptor proteins and components of
the nuclear pore complex, thereby causing the export of mRNAs to the cytoplasm
(Cullen, 2003; Izaurralde, 2002; Lei and Silver, 2002; Reed and Hurt, 2002; Stutz and
Izaurralde, 2003). Association of Btf and TRAP150 with the export factor NXF1/TAP
(Lee et al., 2010; Sarras et al., 2010) raises another possibility for the role of Btf and
TRAP150 in mRNA export as NXF1/TAP is not detected at active transcription sites
(Custodio et al., 2004). So one possibility is that Btf or TRAP150 serve as adaptor
proteins to the export factor TAP and assist in the recruitment of mRNA from the sites of
active transcription to nuclear pore complexes for export to the cytoplasm consistent
with previous studies showing interaction of Btf with nuclear lamins (Haraguchi et al.,
2004; Wilson and Foisner, 2010). Consistently, our exon array data showed an
upregulation of all the nuclear pore complex proteins (NUPs) upon Btf depletion. Hence,
the increase in the polyadenylated RNA in cytoplasm in Btf-depleted cells might be
reflecting a subsequent increase in the export factors' transcripts. It will be interesting in
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the future to know what effect Btf/TRAP depletion has on the transcripts that encode
EJC and nuclear pore complex proteins.
Another possibility arises from a previous report that showed TRAP150 as a part
of SNARP complex stabilized Cyclin D1 mRNA by recruiting an essential splicing factor
U2AF56, thereby protecting it from premature degradation (Bracken et al., 2008). This
function could be attributed to either Btf or TRAP150 as both the proteins were depleted
together in that study. A third possibility is that Btf and/or TRAP150 could alter the
subnuclear trafficking of mature transcripts prior to export. A recent study shows that
perispeckles are sites for EJC assembly (Daguenet et al., 2012). Perispeckles are
distinct from nuclear speckles and are sites in between sites of active transcription and
IGCs (Daguenet et al., 2012). Nascent transcripts, once released from transcription
sites, are not randomly distributed in nucleus but are attracted to nuclear speckles
(Vargas et al., 2011). Similarly, the EJC components assembled will also be required to
be transported to nuclear speckles usually via protein-protein interactions with SR
proteins, and Btf or TRAP150 might be serving as a link for recruitment of EJC protein
to nuclear speckles via RS-RS domain interactions with Btf/TRAP150, SRSF1 and EJC
factor Magoh. This could explain the increase in the cytoplasmic polyadenylated RNA
distribution in Btf-depleted cells. Btf interaction with the EJC factors at nascent
transcripts might be a mechanism for the cell to prevent premature degradation. Future
studies to determine the change in cellular distribution of endogenous genes in Btf- or
TRAP150-depleted cells will shed light in this hypothesis. Overall my data suggests a
novel involvement of Btf and not TRAP150 in regulating the cellular distribution of
mRNA.
Btf and TRAP150 are important in regulating cell cycle progression in HeLa cells.
In this study, I report that Btf and TRAP150, play an important role during normal
cell cycle progression through mitosis. My results demonstrated that reduction in the
levels of Btf (Figure 33) or TRAP150 (Torres-Munoz, 2012)or both (Figure 47) causes
misalignment of chromosomes at metaphase. Reduction in the levels of different SR
proteins or splicing factors has been previously implicated to cause cell cycle defects
(Kittler et al., 2004) or genomic instability (Li and Manley, 2005a; Xiao et al., 2007).
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Furthermore, the flow cytometry analysis of asynchronous HeLa cells showed an
increase of cells in G2/M phase of the cell cycle (Figure 35). Consistently, there was 7%
increase seen in the mitotic index in Btf-depleted cells (Figure 36) that suggests that the
cells are either arresting at metaphase or cell cycle progression is delayed. It has been
previously demonstrated that single unattached kinetochore is sufficient to prevent
progression to anaphase due to checkpoint activation (Li and Nicklas, 1995; Rieder et
al., 1994). Mitotic checkpoint proteins such as Mad2, Mad1, BubR1, BUB1 localize to
unattached kinetochores during early mitosis, and become reduced upon attachment
and proper tension (Fang, 2002; Hoffman et al., 2001; Howell et al., 2004; Musacchio
and Hardwick, 2002; Musacchio and Salmon, 2007; Tang et al., 2001). Our data
supports this idea as the mitotic checkpoint proteins CENP-E, CENP-F, and Aurora B
localized to the unattached chromosomes in Btf-depleted cells (Figures 37-40).
However, cells depleted of Btf or TRAP150 did not show mitotic arrest (Figure 36). This
could be because the recruitment and activation of checkpoint proteins at a few
misaligned chromosomes is not enough to generate a sufficient "wait anaphase" signal.
Because our studies used unsynchronized cells, a better way to measure a more robust
change in cell cycle progression would involve synchronizing the cells in G2/M prior to
depletion by siRNA. However, synchronization of HeLa cells in G2/M phase was
intricate, as the cells could not survive nocodazole and double thymidine treatment
inour experimental conditions.
Alternatively, in order to follow the fate of the misaligned chromosomes, I
performed time-lapse microscopy in HeLa cells stably expressing H2B-YFP transfected
either with control siRNA duplexes or Btf siRNA duplexes. Time lapse microscopy
results revealed that Btf-depleted cells are not prevented from entering anaphase, but
take a longer time to progressfrom prometaphase to telophase (Figure 43) as compared
to the control siRNA transfected cells (Figure 42). This was consistent with flow
cytometry data showing an increase in the 2N population of cells following Btf (B1 or
B2) and TRAP150 (T1 or T4) depletion (Figure 36). One possibility regarding the fact
that depletion of Btf or TRAP150 revealed defects in cell cycle progression but did not
show dramatic mitotic arrest is that depletion of one protein might lead to increased
expression of its homolog, thereby compensating for the mitotic functions these proteins
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may have in common. Thus, next I examined the effects of double depletion of Btf and
TRAP150 in HeLa cells. Depletion of Btf and TRAP150 together in HeLa cells stably
expressing H2B-YFP revealed that there were fragmented nuclei, which suggests that
there was improper segregation of chromosomes to daughter nuclei and thus aberrant
cytokinesis. This was consistent with flow cytometry data showing an increase in
number of cells with 4N DNA content and mitotic arrest at 72 hours (Figure 44 and
Figure 46B). Cell growth analysis revealed that depletion of Btf or TRAP150 causes cell
death consistent with previous studies (McPherson et al., 2009) and reduced growth
that is more prominent upon combined Btf and TRAP150 depletion (Figure 45).
Immunofluorescence results showed that depletion of both Btf and TRAP150 in HeLa
cells causes severe defects in microtubule attachment and chromosomal misalignment
(Figure 46A). Time-lapse microscopy revealed that the metaphase cells with
chromosomal alignment defects in Btf and TRAP150 depleted cells failed to progress
through mitosis and resulted in metaphase arrest (Figure 48).
Mad2 (mitotic arrest deficient-like 1; MAD2L1), BubR1 (budding uninhibited by
benzimidazoles 1 homolog B; BUB1B) and Bub3 are important mitotic checkpoint
kinases. These are regarded as the major effectors of the mitotic checkpoint. Both
Mad2 and BubR1 directly bind Cdc20 (Musacchio and Salmon, 2007). Mitotic defects
seen upon Btf or TRAP150 depletion could be a result of the up-regulation of mitotic
checkpoint genes such as AURK-B, BubR1, BUB3, CENP-E, CENP-F and NDC80
(Figure 53), consistent with a previous report that demonstrated mitotic checkpoint
dysfunction due to altered expression levels of known checkpoint proteins (Bharadwaj
and Yu, 2004). Our microarray data also supports this report. Specifically, the increased
Aurora B protein expression (Figure 40) and its transcript up-regulation upon Btf
depletion (Figure 53) poses two possibilities: Btf depletion in cells leads to chromosomal
misalignment via activation of Aurora kinase B directly and thus increase its expression
at protein and mRNA levels, or Btf regulates expression of Aurora B transcripts
indirectly by affecting the pathway upstream. Thus, on basis of our microarray data and
earlier results that support Btf's role in mRNA processing, I speculate that Btf might be
having adirect effect on cell cycle progression by regulating the transcripts of major cell
cycle regulators at transcirption level or by affecting the splicing of these transcripts. A
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way to test will include looking at alternative splicing defects on endogenous mitotic
checkpoint gene transcripts by RT-PCR.
High through-put RNAi screening by time-lapse imaging of live human cells and
mitocheck screening found 27 out of 150 core components of human spliceosome
found to be required in mitosis (Neumann et al., 2006; Neumann et al., 2010; Swedlow
et al., 2010). Evidence exists to support both direct and indirect role of splicing factors in
mitosis (Haufman et al., 2010). The misalignment of chromosomes at metaphase
observed upon Btf (Figure 33) or TRAP150 depletion (Torres-Munoz, 2012), could be
an indirect effect of these proteins on mitotic progression as a consequence of
regulating the expression levels of other major cell cycle regulators. One possible
explanation is that since Btf and TRAP150 are nuclear speckle components and SR
proteins, the metaphase defect is a consequence of defects in pre-mRNA splicing or
some other step of mRNA processing. In this scenario, the depletion of splicing factor
(Btf or TRAP150) may lead to impaired pre-mRNA processing of genes essential for cell
division processes, in turn resulting in depletion of the corresponding proteins. Support
of this explanation comes from our micorarray data that shows an important cell cycle
regulatorgene CENP-M to be alternatively spliced upon Btf depletion (Tables 6, 7).
CENP-M is a factor essential for centromere assembly (Foltz et al., 2006). Depletion of
CENP-M by siRNA distrupted the recruitment of CENP-A Nucleosome associated
complex (NAC) (Foltz et al., 2006). Additionally, siRNA depletion of CENP-M also
caused mitotic defects such as failure in chromosome congression, thus yeilding an
increased proportion of cells in prometaphase. Consequence of altered splicing of this
gene is unknown. It will be interesting in future to determine the effects of Btf depletion
on splicing of CENP-M gene transcripts. Although, we did not see a role for Btf in
splicing of BTM reporter transcripts, it is possible that Btf or TRAP150 may be regulating
the splicing of a subset of endogenous mitotic genes. Further work geared towards
establishing the role of Btf or TRAP150 in regulating splicing of major mitotic regulators
would involve validation of altered splice site choice for the most significant exon array
mitotic gene targets whose splicing is affected by Btf or TRAP150 depletion (Tables 6,
7).
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Cell cycle checkpoints are present at several stages of the eukaryotic cell cycle
and are responsible for maintaining genomic integrity. These include G1/S checkpoint,
G2/M DNA damage checkpoint and the mitotic spindle assembly checkpoint. Protein
kinase Cδ activated Btf and thus induced p53 expression (Liu et al., 2007). Protein
kinase Cδ activity has been previously linked to promoting apoptosis and to induce cell
cycle arrest in the presence of DNA damage (LaGory et al., 2010). p53 is a key cell
cycle regulator and its frequent loss or mutation causes various cancers (Hollstein et
al., 1991). Based on these findings, the effect of Btf depletion on cell cycle progression
could be a consequence of its role in controlling processing of transcripts that encode
these genes. Also, Btf and TRAP150 were identified in a complex with SNIP1 that
regulates Cyclin D1 mRNA stability (Bracken et al., 2008). Cyclin D1 is a major
regulator of G1 phase of the cell cycle and an oncogene (Tashiro et al., 2007).
Expression of Btf was cell cycle regulated, with higher levels in G1 consistent with
higher levels of cyclin D1, depleting in S-phase and then again high in G2/M phase of
the cell cycle (Bracken et al., 2008). Alternatively, TRAP150 levels were consistent
throughout the cell cycle (Bracken et al., 2008). This suggests that both Btf and
TRAP150 might be involved in different cell cycle regulation events by means of their
distinct interacting partners. Future experiments done to reveal the interacting partners
of Btf and TRAP150 from mitotic cell extracts will shed light on their distinct functions in
cell cycle progression. Production of mature Cyclin D1 transcripts was dependent on the
SNARP complex; thus, the defects seen in mitosis upon Btf- or TRAP150-depletion may
be as a consequence of the immature degradation of Cyclin D1 mRNA. Aneuploidy is
the major cause of majority of cancers (Kops et al., 2005). Tumor cells become
aneuploid as a result of aberrant mitotic division, caused by a defective mitotic
checkpoint response. Taken altogether, our data suggests a role of two SR proteins Btf and TRAP150 in regulation of chromosomal alignment at metaphase. Northern
analysis of mRNA from eight cancer cell lines revealed an absence of Btf mRNA in Raji
cells derived from Burkitt's lymphoma (Kasof et al., 1999). This cell line has 6q
chromosomal deletions consistent wiht the fact that Btf localizes to chromosome 6q
region. The chromosomal misalignment defects observed upon single depletion of Btf or
TRAP150 or double depletion of Btf and TRAP150 in HeLa cells suggests that these
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proteins might have a major role in regulating proper cell cycle progression and thus in
tumorigenesis and cancer progression.
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CHAPTER 6
Conclusions
Btf andTRAP150 affects the subcellular localization of mRNA.
We have demonstrated a novel function for Btf in mRNA processing. Previous
studies have speculated a role for TRAP150 as splicing activator and in nuclear mRNA
decay (Lee et al., 2010), but in that study the role of Btf in those processes was not
clear. Using immunolocalization studies at two different reporter loci, we showed that
both Btf and TRAP150 are recruited to active transcription sites in-situ along with
splicing factor SRSF1 and exon junction complex protein Magoh consistent with the fact
that they are identified in the same complex (this study; Lee et al., 2010). Additionally,
we showed that depletion of Btf and not TRAP150 causes an increase in the BTM
reporter transcripts and also at global level, causes an increase in polyadenylated RNA
in the cytoplasm. Our data here are most consistent of a distinct role of Btf and
TRAP150 in regulating the cellular distribution of mRNA via their interaction with EJC
factor Magoh or the export factor TAP/NXF1 as suggested by others (Figure 54). The
data also indicates thatBtf and TRAP150 might act as adaptor proteins to the EJC and
faciliate the export of mRNAs from the nuclear pore to cytoplasm for further translation
into proteins. Another possibility is that Btf, having the characteristic RS domain that is
essential for protein-protein interaction among SR proteins, may act as adaptor to the
exon junction complex (EJC) proteins. This might facilitate the recycling of non-shuttling
EJC factors in and out of the nuclear speckles after the mature transcript is exported to
the cytoplasm for translation. Overall, my findings sugests that Btf plays an important
role in nuclear mRNA retention, a function that is distinct from its homologue protein
TRAP150. Thus, it can also be concluded that though sharing such high degree of
similarity, Btf and TRAP150 may have their distinct cellular functions by regulating
different subset of genes. Further experiments needs to be done to identify specific
endogenous gene targets for both Btf and TRAP150.
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Figure 54. A model proposing that Btf or TRAP150 behave as adaptor proteins,
thereby regulates the cellular distribution of mRNA.
Btf and TRAP150 act as adaptor proteins to the export factor TAP/NXF1 or to EJC
factor Magoh through their characteristic RS domain and faciliate the export of mRNAs
from the nuclear pore to cytoplasm for further translation into proteins. Both Btf and
TRAP150 might be important in distinct stages of mRNA export and thereby influence
the mRNA distribution in cells.
Blue lines - introns, red lines - exons, red line in cytoplasm - mature mRNA, dark blue
circle - RNP complexes in nuclear speckles (NS), light blue circles - EJC, red circle - Btf,
yellow circle - TRAP150, NE - nuclear envelope.
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Btf and TRAP150 are important for regulation of cell cycle progression.
We demonstrated that depletion of Btf or TRAP150 causes cell cycle defects.
This is the first time that these two SR proteins have been shown to have any role in
mitosis. Immunofluorescence, flow cytometry and mitotic cell counts all demonstrated
that the cells depleted of Btf or TRAP150 do not demonstrate proper chromosome
segregation at metaphase. Additionally, time-lapse microscopy results suggested that
majority of the misaligned chromosomes in Btf-depleted cells could align back at
metaphase but there was a prolongation observed in metaphase. Moreover, a small
population of the Btf-depleted cells showing misaligned chromosomes could not
proceed to anaphase thus causing the cell to arrest at mitosis. A possible explanation of
this could be that since Btf and TRAP150 compensate for each other, the cells depleted
of either Btf or TRAP150 do not go under mitotic arrest, but instead delay in mitosis is
observed. Interestingly, a double depletion of Btf and TRAP150 caused mitotic arrest
as detected by the phospho-H3 antibody. This indicates that both Btf and TRAP150 are
esential for cell cycle progression in HeLa cells. Although, a more extensive time-lapse
microscopy needs to be done to get a definite answer. Exon array data demonstrated
cell cycle as the first process to be affected by both Btf and TRAP150 depletion. Also,
major mitotic checkpoint proteins were upregulated 2-fold or higher upon Btf or
TRAP150 depletion. Also, the exon array showed that differentially expressed genes
with roles in cell cyle regulation were affeted upon Btf or TRAP150 depletion. Based on
these findings, I speculate an indirect role of Btf or TRAP150 in maintaining
chromosomal alignment at metaphase by influencing expression levels or alternative
splicing of the major mitotic regulators. The list of affected transcripts from my exon
array study could be a useful starting point to identify new mitotic gene regulators.
Additionally, my observations that TRAP150 depletion causes defects in later stages of
mitosis such as telophase, unlike Btf, suggests distinct roles for Btf and TRAP150 in
mitotic regulation. This could result from Btf targeting a different subset of transcripts
from TRAP150. Further, it would be interesting to understand the role of both these
proteins in cell cycle progression through mitosis and to determine which mitotic genes
are regulated by Btf and TRAP150.
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APPENDIX A

Table 1: Top 20 most significant genes up-regulated upon Btf
depletion in Exon array.
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Table 2: Top 20 most significant genes down-regulated upon Btf
depletion in Exon array.
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Table 3: Top 20 most significant genes Up-regulated upon
TRAP150 depletion in Exon Array
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Table 4: Top 25 most significant genes Down-regulated upon
TRAP150 depletion in Exon Array
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Table 5. List of genes showing Down-regulation of Exon inclusion
(Exon Skipping) upon Btf depletion (BtfSi1) in Exon Array.
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Table 6. List of genes showing Up-regulation of Exon inclusion upon
Btf depletion (BtfSi1) in Exon Array.
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Table 7. List of genes showing Down-regulation of Exon inclusion
(Exon Skipping) upon TRAP150 depletion (TRAPSi4) in Exon Array.
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Table 8. List of genes showing Up-regulation of Exon inclusion upon
TRAP150 depletion (TRAPSi4) in Exon Array.
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Table 9: Primer sequences for mitotic gene targets
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Table 10. Differentially expressed major chromosomal passenger
genes after Btf and TRAP150 depletion in Affymetrix HumanExon10ST
Array.

( ) indicate Ingenuity iReport results.
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